Настройки

Укажите год
-

Небесная энциклопедия

Космические корабли и станции, автоматические КА и методы их проектирования, бортовые комплексы управления, системы и средства жизнеобеспечения, особенности технологии производства ракетно-космических систем

Подробнее
-

Мониторинг СМИ

Мониторинг СМИ и социальных сетей. Сканирование интернета, новостных сайтов, специализированных контентных площадок на базе мессенджеров. Гибкие настройки фильтров и первоначальных источников.

Подробнее

Форма поиска

Поддерживает ввод нескольких поисковых фраз (по одной на строку). При поиске обеспечивает поддержку морфологии русского и английского языка
Ведите корректный номера.
Ведите корректный номера.
Ведите корректный номера.
Ведите корректный номера.
Укажите год
Укажите год

Применить Всего найдено 7996. Отображено 100.
15-03-2012 дата публикации

Methods to produce polymer nanoparticles and formulations of active ingredients

Номер: US20120065071A1
Принадлежит: Vive Nano Inc

The present invention provides a composition including a polymer nanoparticle and at least one agricultural active compound incorporated with the nanoparticle, wherein the nanoparticle are less than 100 nm in diameter, and the polymer includes a polyelectrolyte.

Подробнее
22-03-2012 дата публикации

Medical device with degradation-retarding coating

Номер: US20120071974A1
Принадлежит: Sofradim Production SAS

The present disclosure relates to implantable bioabsorbable medical devices having an amphiphilic coating for delaying the degradation of the device and methods of making such devices.

Подробнее
01-11-2012 дата публикации

Soluble coating comprising polyelectrolyte with hydrophobic counterions

Номер: US20120276185A1
Принадлежит: Individual

The present invention provides an implantable device having a biosoluble coating comprising a polyelectrolyte and a counterion and the methods of making and using the same.

Подробнее
17-01-2013 дата публикации

Method for synthesizing calixarene and/or cyclodextrin copolymers, terpolymers and tetrapolymers, and uses thereof

Номер: US20130018164A1
Автор: Mohamed Skiba
Принадлежит: Individual

The present invention relates to a novel method for synthesizing a composition of polymers, copolymers, terpolymers and tetrapolymers, and to the use thereof, said composition being made from: cyclodextrins, in particular α-cyclodextrin, β-cyclodextrin, γ-cyclodextrin, the derivatives thereof or the corresponding mixtures thereof; and/or calix[n]arene(s) and/or calix[n]arene derivative(s) and/or a mixture of two or more different calix[n]arenes selected from calix[n]arenes (n=4-20) and/or the derivatives thereof, and to the uses thereof. A method was developed on the basis of bulk polycondensation by heating. The invention can be used in the pharmaceutical, human medicine, veterinary medicine, chemistry, separation chemistry, environmental, electronics, biology, diagnostics, phytosanitation, medicinal food, agri-food, and cosmetics fields, and in the nutraceutical field and in the field of molecular imprints (MIP).

Подробнее
31-01-2013 дата публикации

Film, resin composition and polymer

Номер: US20130030116A1
Принадлежит: JSR Corp

Provided is a film comprising a polymer that comprises a structural unit represented by the following formula (1), wherein at least part of the terminal structure of the polymer is at least one structure selected from the group consisting of structural units represented by the following formula (2) and structural units represented by the following formula (3).

Подробнее
18-04-2013 дата публикации

HEMOSTATIC COMPOSITIONS

Номер: US20130096082A1
Принадлежит:

The invention discloses a hemostatic composition composing chitin or a water insoluble chitin derivative, especially water insoluble chitosan, in particulate form, wherein the composition is present in paste form. 1. A hemostatic composition comprising chitin or a water insoluble chitin derivative , in particulate form , wherein the composition is present in paste form.2. The hemostatic composition according to claim 1 , wherein the composition additionally comprises crosslinked gelatin.3. The hemostatic composition according to claim 2 , wherein the crosslinked gelatin is glutaraldehyde-crosslinked gelatin or genipin-crosslinked gelatin.4. The hemostatic composition according to claim 1 , wherein the chitin or the water insoluble chitin derivative is mixed with crosslinked gelatin in a ratio (in % (w/w)) of 5:95 to 80:20.5. The hemostatic composition according to any one of claim 1 , wherein the composition additionally comprises a biocompatible polymer suitable for use in hemostasis.6. The hemostatic composition according to claim 5 , wherein the biocompatible polymer suitable for use in hemostasis is a crosslinked protein claim 5 , a crosslinked polysaccharide claim 5 , a crosslinked biologic polymer claim 5 , a crosslinked non-biologic polymer; or mixtures thereof.7. The hemostatic composition according to for use in the treatment of an injury selected from the group consisting of a wound claim 1 , a hemorrhage claim 1 , a damaged tissue claim 1 , a bleeding tissue claim 1 , and a bone defect.8. A method of treating an injury selected from the group consisting of a wound claim 1 , a hemorrhage claim 1 , a damaged tissue and a bleeding tissue comprising administering a hemostatic composition according to to the injury.9. A kit for making a flowable paste of chitin or a water insoluble chitin derivative for the treatment of an injury selected from the group consisting of a wound claim 1 , a hemorrhage claim 1 , a damaged tissue claim 1 , and bleeding tissue claim ...

Подробнее
09-05-2013 дата публикации

POLYPROPYLENE WITH SPECIFIC CALCIUM STEARATE CONTENT FOR SPECIAL CAPACITORS

Номер: US20130115471A1
Автор: Jacobs Franciscus
Принадлежит: Borealis AG

Capacitor film comprising a biaxially oriented polypropylene (BOPP) and more than 100 to below or equal 400 ppm of an alkali earth fatty acid salt. 116-. (canceled)17. Capacitor film comprising:(a) at least 90 wt. % of a biaxially oriented polypropylene (BOPP), and(b) more than 100 to below or equal 400 ppm of an alkali earth fatty acid salt.18. Capacitor film according to claim 17 , wherein the biaxially oriented polypropylene (BOPP) has a draw ratio in machine direction of at least 4.0 and a draw ratio in transverse direction of at least 4.0.19. Capacitor film according to claim 17 , wherein the biaxially oriented polypropylene (BOPP) is the only polymer component within the capacitor film.20. Capacitor film according to claim 17 , wherein the biaxially oriented polypropylene (BOPP) is a propylene homopolymer.21. Capacitor film according to claim 17 , wherein the capacitor film and/or the biaxially oriented polypropylene (BOPP) has/have an ash content below 100 ppm.22. Capacitor film according to claim 17 , wherein the biaxially oriented polypropylene (BOPP) has:{'sup': '13', '(a) <2,1>erythro regiodefects of not more than 0.4 mol. % determined by C-spectroscopy,'}and/or(b) a branching g′ valve of at least 0.9.23. Capacitor film according to claim 17 , wherein the biaxially oriented polypropylene (BOPP) has:(a) a molecular weight distribution (MWD) measured according to ISO 16014 of at least 2.8,and/or{'sub': '2', '(b) a melt flow rate MFR(230° C.) measured according to ISO 1133 in the range of 1.0 to 6.0 g/10 min.'}24. Capacitor film according to claim 17 , wherein the capacitor film and/or the biaxially oriented polypropylene (BOPP) has/have:{'sub': 'm', '(a) a melting temperature (T) measured according to ISO 11357-3 of at least 145.0° C.,'}and/or{'sub': 'c', '(b) crystallization temperature (T) measured according to ISO 11357-3 of at least 113° C.'}25. Capacitor film according to claim 17 , wherein the capacitor film and/or the biaxially oriented polypropylene ...

Подробнее
23-05-2013 дата публикации

AQUEOUS BINDER FOR GRANULAR AND/OR FIBROUS SUBSTRATES

Номер: US20130127085A1
Принадлежит:

The invention provides an aqueous binder for granular and/or fibrous substrates, said binder comprising, as active constituents, a polyamine and a saccharide compound. 1. An aqueous binder for granular and/or fibrous substrates , said binder comprising , as active constituents ,a) at least one organic compound having at least two primary amino groups [polyamine A], andb) at least one saccharide compound S,c) the weight ratio of the at least one polyamine A to the at least one saccharide compound S being 1:99 to 80:20.2. The aqueous binder according to claim 1 , wherein the saccharide compounds S used are monosaccharides claim 1 , oligosaccharides and/or polysaccharides claim 1 , and the substitution products or derivatives thereof.3. The aqueous binder according to or claim 1 , wherein the at least one saccharide compound S used is glucose claim 1 , mannose claim 1 , galactose claim 1 , xylose claim 1 , fructose claim 1 , ribose claim 1 , lactose claim 1 , maltose claim 1 , sucrose claim 1 , maltodextrin and/or glucose syrup.4. The aqueous binder according to any of to claim 1 , wherein the at least one polyamine A has a molecular weight of ≧60 and ≦10 000 000 g/mol.5. The aqueous binder according to any of to claim 1 , wherein the at least one polyamine A has ≧5 primary amino groups per mole.6. The aqueous binder according to claim 5 , wherein the polyamine A is a homopolymer claim 5 , containing vinylamine units claim 5 , of a vinylcarboxamide with a hydrolysis level of ≧50 mol % and/or is a polyethyleneimine with branched structure.7. The aqueous binder according to any of to claim 5 , wherein the weight ratio of the at least one polyamine A to the at least one saccharide compound S is 5:95 to 50:50.8. The aqueous binder according to any of to claim 5 , wherein the total amount of the organic compounds present alongside the polyamine A and the saccharide compound S in the aqueous binder is ≦30% by weight claim 5 , based on the sum of the total amounts of ...

Подробнее
27-06-2013 дата публикации

METHODS OF MAKING AND USING PRECURSOR POLYELECTROLYTE COMPLEXES

Номер: US20130165525A1
Принадлежит: The Clorox Company

The invention relates to compositions and methods of treatment employing compositions comprising polyelectrolyte complexes. The compositions include a water-soluble first polyelectrolyte bearing a net cationic charge or capable of developing a net cationic charge and a water-soluble second polyelectrolyte bearing a net anionic charge or capable of developing a net anionic charge. The total polyelectrolyte concentration of the first solution is at least 110 millimolar. The composition is free of coacervates, precipitates, latex particles, synthetic block copolymers, silicone copolymers, cross-linked poly(acrylic) and cross-linked water-soluble polyelectrolyte. The composition may be a concentrate, to be diluted prior to use to treat a surface. 1. A method for treating a surface comprising: (1) a water-soluble first polyelectrolyte bearing a net cationic charge or capable of developing a net cationic charge;', '(2) a water-soluble second polyelectrolyte bearing a net anionic charge or capable of developing a net anionic charge;', '(3) wherein the first solution is free of coacervates, precipitates, latex particles, synthetic block copolymers, silicone copolymers, cross-linked poly(acrylic) and cross-linked water-soluble polyelectrolyte; and', '(4) wherein the total polyelectrolyte concentration of the first solution is at least 110 millimolar;, '(a) providing a first solution comprising(b) providing a second solution comprising a solvent;(c) contacting said first solution with the second solution to form a polyelectrolyte complex solution;(d) contacting said polyelectrolyte complex solution to the surface wherein said polyelectrolyte complex solution treats the surface.2. The method of claim 1 , wherein the first solution is a concentrate claim 1 , the method further comprising diluting the concentrate with water to form a dilute composition comprising the polyelectrolyte complex claim 1 , prior to contacting the surface with the dilute composition claim 1 , and ...

Подробнее
11-07-2013 дата публикации

ORGANIC ACID CARBOHYDRATE BINDERS AND MATERIALS MADE THEREWITH

Номер: US20130174758A1
Автор: Mueller Gert R. J.
Принадлежит: Knauf Insulation GmbH

A binder comprising a polymeric binder comprising the products of a carbohydrate reactant and organic acid is disclosed. The binder is useful for consolidating loosely assembled matter, such as fibers. Fibrous products comprising fibers in contact with a carbohydrate reactant and an organic acid are also disclosed. The binder composition may be cured to yield a fibrous product comprising fibers bound by a cross-linked polymer. Further disclosed are methods for binding fibers with the carbohydrate based binder using an organic acid. 1. A binder comprising a polymeric product of a carbohydrate reactant , an amine base , and an organic acid , wherein{'sub': m', 'n, 'the organic acid is R—O(═O)(—OH),'}Q is phosphorus (P), m is 1, and n is 2 or Q is sulfur (S), m is 2, and n is 1, andR is alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, heteroalkyl, heteroalkenyl, cycloheteroalkyl, cycloheteroalkenyl, aryl, or arylalkyl, each of which is optionally substituted.2. The binder of claim 1 , in which the organic acid is characterized by at least one of the following embodiments:a) wherein R is alkyl, cycloalkyl, heteroalkyl, cycloheteroalkyl, alkenyl, cycloalkenyl, or aryl each of which is optionally substituted;b) wherein R is selected from the group consisting of phenyl, benzyl, a tolyl, a xylyl, and a naphthalenyl, each of which is optionally substituted;c) wherein R is 4-methylphenyl;d) wherein R is selected from the group consisting of 2-aminophenyl, 3-aminophenyl, 2-methylphenyl, 3-methylphenyl, 2,3-dimethylphenyl, and 2,4-dimethylphenyl;{'sub': 1', '24, 'e) wherein R is an alkyl selected from the group consisting of C-C, each of which is optionally substituted;'}{'sub': 1', '8, 'f) wherein R is an alkyl from the group consisting of C-C, each of which is optionally substituted;'}g) wherein R is selected from the group consisting of methyl, ethyl, 2-amino-ethyl, piperidinyl, and trifluoromethyl; andh) wherein R is selected from the group consisting of 2-sulfophenyl, 3- ...

Подробнее
18-07-2013 дата публикации

LINEAR CYCLODEXTRIN COPOLYMERS

Номер: US20130184453A1
Принадлежит: California Institute of Technology

Linear cyclodextrin copolymers and linear oxidized cyclodextrin copolymers containing an unoxidized and/or an oxidized cyclodextrin moiety integrated into the polymer backbone are described. Methods of preparing such copolymers are also described. The linear cyclodextrin copolymer and linear oxidized cyclodextrin copolymer of the invention may be used as a delivery vehicle of various therapeutic agents. 145-. (canceled)46. A method of preparing a β-cyclodextrin-PEG copolymer , comprising:{'sup': A', 'D', 'A', 'D, 'a. providing a salt of 6,6-diamino-6,6-deoxy-β-cyclodextrin in a suspension;'}b. treating the suspension with a polyethylene glycol diacid chloride;c. allowing the treated suspension to become a homogeneous solution;d. removing solvent from the homogeneous solution to generate a residue;e. subjecting the residue to gel permeation chromatography; andf. recovering the copolymer.47. The method of claim 46 , wherein the polyethylene glycol diacid chloride is polyethylene glycol 600 diacid chloride.48. The method of claim 46 , wherein the suspension further comprises triethylamine and anhydrous N claim 46 ,N-dimethylacetamide. This application is a continuation of U.S. application Ser. No. 12/966,647, filed Dec. 13, 2010, which is a continuation of U.S. application Ser. No. 11/358,976, filed Feb. 21, 2006, which is a continuation of U.S. application Ser. No. 09/339,818, filed Jun. 25, 1999, now U.S. Pat. No. 7,091,192, which is a continuation-in-part of U.S. application Ser. No. 09/203,556, filed Dec. 2, 1998, now U.S. Pat. No. 6,509,323, which claims the benefit of U.S. Provisional Application Ser. No. 60/091,550, filed Jul. 1, 1998, each of which is herein incorporated by reference in its entirety.The invention relates to linear cyclodextrin copolymers and linear oxidized cyclodextrin copolymers. These copolymers, respectively, contain a cyclodextrin moiety, unoxidized or oxidized, as a monomer unit integrated into the copolymer backbone. The invention also ...

Подробнее
25-07-2013 дата публикации

CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTICS DELIVERY

Номер: US20130190450A1
Принадлежит: CERULEAN PHARMA INC.

The present invention relates to novel compositions of therapeutic cyclodextrin containing polymeric compounds designed as a carrier for small molecule therapeutics delivery and pharmaceutical compositions thereof. These cyclodextrin-containing polymers improve drug stability and solubility, and reduce toxicity of the small molecule therapeutic when used in vivo. Furthermore, by selecting from a variety of linker groups and targeting ligands the polymers present methods for controlled delivery of the therapeutic agents. The invention also relates to methods of treating subjects with the therapeutic compositions described herein. The invention further relates to methods for conducting pharmaceutical business comprising manufacturing, licensing, or distributing kits containing or relating to the polymeric compounds described herein. 135.-. (canceled)36. A method of making a water soluble linear polymer camptothecin conjugate comprising:providing a water soluble linear polymer comprising cyclodextrin moieties and comonomers which do not contain cyclodextrin moieties (comonomers), wherein the cyclodextrin moieties and comonomers alternate in the water soluble linear polymer and wherein the water soluble linear polymer comprises at least four cyclodextrin moieties and at least four comonomers; andcovalently attaching camptothecin moieties to the water soluble linear polymer, thereby making a water soluble linear polymer camptothecin conjugate, wherein the camptothecin moieties can be cleaved from the water soluble linear polymer conjugate under biological conditions to release the camptothecin moieties.37. The method of claim 36 , wherein each of the camptothecin moieties is attached to the water soluble linear polymer via a linker.38. The method of claim 36 , wherein the water soluble linear polymer is made by a process comprising:providing cyclodextrin moiety precursors,providing comonomer precursors, andcopolymerizing the cyclodextrin moiety precursors and the ...

Подробнее
01-08-2013 дата публикации

Film containing alginate membrane and manufacturing method of the same

Номер: US20130196068A1
Принадлежит: BIOSOL Tech CORP Ltd

A film containing alginate membrane and a manufacturing method of the same are revealed. A film carrier is used to absorb liquid and is treated by two separate and continuous coating processes. At least one surface of the film carrier is coated with a layer of alginate solution containing a certain percent of sodium alginate or potassium alginate by weight and then is coated with a layer of salt water solution containing a certain percent of divalent metal ions. Then crosslinking occurs between the alginate in the alginate solution and the divalent metal ions in the salt solution on the surface of the film carrier or infiltrating into the film carrier so as to form a hydrogel complex membrane having a network structure. Thus the continuous and fast mass-production of the film is achieved.

Подробнее
01-08-2013 дата публикации

POLYMERS FOR BIOMATERIALS AND THERAPEUTICS

Номер: US20130196948A1
Принадлежит: MASSACHUSETTS INSITUTE OF TECHNOLOGY

Described herein are inventive compositions and methods relating to polymer conjugates and, in particular, to polymer conjugates having pendant side groups comprising ring moieties. In one aspect, embodiments are generally related to compositions that mimic naturally-occurring polyphenol compounds. The compositions comprise, in some embodiments, a polymer backbone having a plurality of hydroxyaromatic pendant side groups or derivatives thereof. For example, in some cases, a pendant side group may be a phenol or a substituted derivative thereof. In some cases, the pendant side group may be an oxidized hydroxyaromatic group, such as a quinone. In some embodiments, self-assembled structures comprising one or more of the polymer conjugates are provided. For example, the polymer conjugates may be combined with a complexing agent to form a particle. In some cases, a polymer conjugate may form a hydrogel. In some embodiments, the self-assembled structures may contain an agent, such as a pharmaceutically active agent. Also provided are methods and kits for forming the compositions, methods of using the compositions, and the like. 2. The composition of claim 1 , wherein the polysaccharide is cyclic.3. The composition of claim 2 , wherein the polysaccharide is cyclodextrin.4. The composition of claim 2 , wherein the polysaccharide is linear.5. The composition of claim 4 , wherein the polysaccharide is dextran.6. The composition of claim 1 , wherein X is a bond.7. The composition of claim 1 , wherein Y is a bond.8. The composition of claim 1 , wherein Rand Rare each claim 1 , independently claim 1 , a hydroxyl group or substituted derivative thereof.9. The composition of claim 1 , wherein Rand Rare each claim 1 , independently claim 1 , a hydroxyl group or substituted derivative thereof.10. The composition of claim 1 , wherein R claim 1 , R claim 1 , and Rare each claim 1 , independently claim 1 , a hydroxyl group or substituted derivative thereof.11. The composition of claim ...

Подробнее
01-08-2013 дата публикации

COMPLEXING AGENTS FOR COMPOSITIONS CONTAINING INCLUSION COMPLEXES

Номер: US20130197210A1
Принадлежит:

The invention provides a composition containing particulate composite of a polymer and a therapeutic agent. The composition also contains a complexing agent. The polymer interacts with the complexing agent in a host-guest or a guest-host interaction to form an inclusion complex. Both the polymer of the particulate composite and the complexing agent may be used to introduce functionality into the therapeutic composition. A therapeutic composition of the invention may be used to deliver the therapeutic agent and to treat various disorders. The invention also relates to a method of preparing a composition of the present disclosure. The invention further relates to a method of delivering a therapeutic agent, using the composition of the present disclosure, where a therapeutically effective amount of a therapeutic composition of the invention may be administered to a mammal (e.g. person or animal) in recognized need of the therapeutic. 110-. (canceled)11. A method of preparing a PEG-terminated β-cyclodextrin-DMS copolymer , comprising:a. providing a β-cyclodextrin(cystamine)-DMS copolymer in a solution;b. adding FMOC-PEG-NHS to the solution;c. lyophilizing the solution to generate a solid;d. dissolving the solid, thereby resulting in FMOC deprotection;e. removing solvent to generate a viscous liquid;f. separating the copolymer from unreacted PEG by anion exchange chromatography; andg. recovering the copolymer.12. The method of claim 11 , wherein the FMOC-PEG-NHS is FMOC-PEG-NHS.13. The method of claim 11 , wherein the solution further comprises NaHCO.14. The method of claim 11 , wherein the solid is dissolved in a solution of piperidine in DMF. This application is a continuation of U.S. application Ser. No. 13/107,024, filed May 13, 2011, now U.S. Pat. No. 8,277,846, which is a continuation of U.S. application Ser. No. 11/588,033, filed Oct. 25, 2006, now U.S. Pat. No. 7,968,123, which is a continuation of U.S. application Ser. No. 10/021,294, filed Dec. 19, 2001, now U. ...

Подробнее
01-08-2013 дата публикации

Nanoparticle chains and Preparation Thereof

Номер: US20130197214A1
Принадлежит: Massachusetts Institute of Technology

Fabrication and arrangement of nanoparticles into one-dimensional linear chains is achieved by successive chemical reactions, each reaction adding one or more nanoparticles by building onto exposed, unprotected linker functionalities. Optionally, protecting groups may be used to control and organize growth. Nanoparticle spheres are functionalized in a controlled manner in order to enable covalent linkages. Functionalization of nanoparticles is accomplished by either ligand exchange or chemical modification of the terminal functional groups of the capping ligand. Nanoparticle chains are obtained by a variety of connectivity modes such as direct coupling, use of linker molecules, and use of linear polymeric templates. In particular, a versatile building block system is obtained through controlled monofunctionalization of nanoparticles. 1. A method for synthesizing a chain of nanoparticles comprising the steps of:providing a plurality of nanoparticles, each nanoparticle having at least one attached linker ligand, at least one of the attached linker ligands on each nanoparticle having at least one reactive functional group; andforming a chain of nanoparticles by linking at least two of the nanoparticles by causing at least one reaction directly between a reactive functional group associated with an attached linker ligand of a first nanoparticle and a reactive functional group associated with an attached linker ligand of a second nanoparticle.2. The method of claim 1 , wherein the step of linking comprises the step of removing at least one protective group from at least one reactive functional group of at least one attached linker ligand.3. The method of claim 1 , further comprising the step of linking additional nanoparticles to the chain of nanoparticles in a step-wise manner until a nanoparticle chain of a desired size and configuration is obtained claim 1 , wherein each additional nanoparticle is linked to the chain of nanoparticles by the step of:causing at least ...

Подробнее
08-08-2013 дата публикации

Method for functionalizing surfaces for analyte detection

Номер: US20130203629A1

The invention relates to a device for detecting analytes, including a plastic substrate at least partially covered by bonding polymers attached to the substrate in a non-covalent manner, said bonding polymers comprising a polysaccharide backbone provided with aromatic groupings and carboxylic acid groupings.

Подробнее
15-08-2013 дата публикации

METHODS AND COMPOSITIONS FOR TREATING WOUNDS UTILIZING CHITOSAN COMPOUNDS

Номер: US20130210761A1
Принадлежит: SYNEDGEN, INC.

Described herein are methods of treating wounds, the method comprising administering to a subject an effective amount of a composition comprising a soluble or derivatized chitosan wherein the soluble or derivatized chitosan when administered contacts the wound, thereby treating the wound. 165-. (canceled)69. (canceled)7173-. (canceled)7579-. (canceled)80. The method of claim 66 , wherein the composition claim 66 , upon administration claim 66 , reduces the healing time or increases the healing rate of the mucositis or ulceration.81. The method of claim 66 , wherein the mucositis or ulceration is associated with inflammation and the composition decreases the inflammation upon administration.82. The method of claim 66 , wherein the composition is administered topically or orally.83. The method of claim 66 , wherein the molecular weight of the functionalized chitosan is between 5 claim 66 ,000 and 1 claim 66 ,000 claim 66 ,000 Da.84. The method of claim 67 , wherein the composition claim 67 , upon administration claim 67 , reduces the healing time or increases the healing rate of the symptom of the chronic disease.85. The method of claim 67 , wherein the symptom of the chronic disease is associated with inflammation and the composition decreases the inflammation upon administration.86. The method of claim 67 , wherein the composition is administered topically or orally.87. The method of claim 67 , wherein the molecular weight of the functionalized chitosan is between 5 claim 67 ,000 and 1 claim 67 ,000 claim 67 ,000 Da.88. The method of claim 68 , wherein the composition claim 68 , upon administration claim 68 , reduces the healing time or increases the healing rate of the wound.89. The method of claim 68 , wherein the composition claim 68 , upon administration claim 68 , decreases the inflammation associated with wound or healing of the wound.90. The method of claim 68 , wherein the composition is administered topically or orally.91. The method of claim 68 , wherein ...

Подробнее
05-09-2013 дата публикации

POLYAMIDE RESIN FILMS AND PROCESSES FOR MANUFACTURING THEM

Номер: US20130230693A1
Автор: Mitadera Jun
Принадлежит: MITSUBISHI GAS CHEMICAL COMPANY, INC.

Provided is a windable thin single layer film comprising a xylylenediamine-based polyamide resin. 1. A polyamide resin film comprising:a polyamide resin which is a polycondensate of a diamine and a dicarboxylic acid,wherein the diamine comprises 70 mol % or more of xylylenediamine, and the polyamide resin film has a thickness of 10 to 50 μm and a surface having a texture.2. The polyamide resin film according to claim 1 ,wherein the polyamide resin film has the texture formed by texturing a surface of a film comprising the polyamide resin with a plurality of texturing rolls comprising a first roll and a second roll positioned opposite to the first roll, and the first roll is positioned such that the film contacts with the first roll after the film is extruded from an extrusion die.3. The polyamide resin film according to claim 1 , wherein the polyamide resin film has a surface roughness of 0.01 to 1 μm.4. The polyamide resin film according to claim 1 , wherein the xylylenediamine is m-xylylenediamine claim 1 , p-xylylenediamine or a mixture of m-xylylenediamine and p-xylylenediamine.5. The polyamide resin film according to claim 1 , wherein the dicarboxylic acid is a dicarboxylic acid comprising 50 mol % or more of a straight chain aliphatic α claim 1 ,ω-dicarboxylic acid having 4 to 20 carbon atoms.6. The polyamide resin film according to claim 1 , wherein the dicarboxylic acid is a dicarboxylic acid comprising 70 mol % or more of a straight chain aliphatic α claim 1 ,ω-dicarboxylic acid having 4 to 20 carbon atoms and 1 mol % or more and less than 30 mol % of isophthalic acid.7. The polyamide resin film according to claim 1 , wherein the dicarboxylic acid is adipic acid claim 1 , sebacic acid or a combination thereof.8. The polyamide resin film according to claim 1 , wherein the polyamide resin is a poly(m-xylylene sebacamide) resin claim 1 , a poly(p-xylylene sebacamide) resin or a poly(m-xylylene/p-xylylene sebacamide) copolymer resin.9. The polyamide resin film ...

Подробнее
12-09-2013 дата публикации

METHODS OF USE OF BIOMATERIAL AND INJECTABLE IMPLANT CONTAINING BIOMATERIAL

Номер: US20130237498A1
Принадлежит: Cutanea Life Sciences, Inc

This invention relates to the use of a biomaterial for the treatment, repair and/or enhancement of bodily tissue insufficiencies of the vocal chords, muscles, ligaments, cartilage, post-operative regions, sexual organs and/or weight supporting areas of the feet as well as other conditions of the bones and joints. The biomaterial for use in the invention may comprise an injectable bioresorbable polysaccharide composition wherein the polysaccharide may be succinochitosan glutamate. This invention also relates to the use of a biomaterial comprising an injectable bioresorbable polysaccharide composition in which resorbable particles may be in suspension, the said particles comprising or consisting essentially of chitin and/or chitosan, which may be free of any additional formulation modifying agents, and a process for manufacturing the same. The invention also includes the use of various medicaments in the biomaterial formulations to enhance the treatment of the affected area of the body. 1. A method of treating and/or repairing vocal chords comprising administering a composition to the vocal chords or surrounding tissue , wherein said composition is in the form of a gel comprising an injectable bioresorbable polysaccharide , and wherein said composition further comprises resorbable particles which are in suspension in said gel , the said particles comprising chitin and/or chitosan.2. The method according to claim 1 , wherein the injectable bioresorbable polysaccharide is chitosan claim 1 , or a derivative thereof claim 1 , having a degree of deacetylation of about 30 to about 95%.3. The method according to claim 1 , wherein the injectable bioresorbable polysaccharide is succinochitosan glutamate.4. The method according to claim 1 , wherein the composition comprises about 0.1 to about 20% chitosan claim 1 , or a derivative thereof claim 1 , as the injectable bioresorbable polysaccharide.5. The method according to claim 1 , wherein the weight percent of resorbable ...

Подробнее
19-09-2013 дата публикации

6-Deoxy-6-Thioether-Amino Acid Cyclodextrin Derivative and Preparation Method Thereof

Номер: US20130244979A1
Автор: Qi Youmao
Принадлежит:

6-deoxy-6-thioether-amino acid cyclodextrin derivative is obtained by condensing an amino acid derivative with halogenated cyclodextrin in presence of alkali. The 6-deoxy-6-thioether-amino acid cyclodextrin derivative includes 6-deoxysulfinyl-6-thioether-amino acid cyclodextrin derivative and 6-deoxysulfonyl-6-thioether-amino acid cyclodextrin derivative. Compounds provided are for reversing neuromuscular relaxation in patients and animals induced by muscular relaxants. The compounds are able to rapidly reverse and antagonize muscular relaxation induced by muscular relaxants and can be administrated in preparing a drug having an antagonist effect on muscular relaxation. The compounds have a general formula (I). 34-. (canceled)5. A method for antagonizing muscular relaxation comprising administrating a drug comprising a therapeutically effective amount of the 6-deoxy-6-thioether-amino acid cyclodextrin derivative as recited in .6. A method for antagonizing muscular relaxation comprising administrating a drug comprising a therapeutically effective amount of the 6-deoxy-6-thioether-amino acid cyclodextrin derivative as recited in . This is a U.S. National Stage under 35 U.S.C 371 of the International Application PCT/CN2011/082577, filed Nov. 21, 2011, which claims priority under 35 U.S.C. 119(a-d) to CN 201010566606.3, filed Nov. 26, 2010.1. Field of InventionThe present invention relates to a chemical pharmaceutical field, and more particularly to a 6-deoxy-6-thioether-amino acid cyclodextrin derivative and a preparation method thereof, mainly comprising a 6-deoxysulfinyl-6-thioether-amino acid cyclodextrin derivative, a 6-deoxysulfonyl-6-thioether-amino acid cyclodextrin derivative, preparation methods thereof, and a method for antagonizing muscular relaxation comprising administrating a drug comprising a therapeutically effective amount of the 6-deoxy-6-thioether-amino acid cyclodextrin derivative, wherein the drug is able to rapidly reverse the muscular relaxation ...

Подробнее
03-10-2013 дата публикации

LAMINATED BODY

Номер: US20130260143A1
Принадлежит:

The invention makes it possible to use a coating liquid of a fine cellulose fiber (a natural material) and to form a coated layer which can be used as a various-functions layer such as a gas barrier layer and water vapor barrier layer etc. by achieving good adhesiveness and coatability of the coating liquid, and as a result, provides a laminated material in which temporal degradation of a substrate and the fine cellulose fiber layer is prevented. The laminated body includes a substrate, an anchor layer arranged on a surface the substrate, and a fine cellulose fiber layer containing a fine cellulose fiber having a carboxy group, wherein the anchor layer contains at least one resin having a carboxy group, sulfonate group, amino group or hydroxyl group. 1. A laminated body comprising:a substrate;an anchor layer on a surface of said substrate; anda fine cellulose fiber layer on said anchor layer, said fine cellulose fiber layer containing a fine cellulose fiber having carboxy groups, whereinsaid anchor layer contains a resin having at least one functional group selected from the group consisting of carboxy group, sulfonate group, amino group and hydroxyl group.2. The laminated body according to claim 1 , wherein said fine cellulose fiber is oxidized cellulose in which said carboxy groups are introduced by an oxidation reaction and a content of said carboxy groups in said fine cellulose fiber is in the range of 0.1-5.5 mmol/g.3. The laminated body according to claim 2 , wherein said fine cellulose fiber has a number average fiber diameter in the range of 0.001-0.200 μm.4. The laminated body according to claim 3 , wherein said carboxy groups in said fine cellulose fiber form ammonium salts or amine salts.5. The laminated body according to claim 3 , wherein said resin contained in said anchor layer is a polyester resin claim 3 , a polyamide resin claim 3 , a polyurethane resin claim 3 , a polyacrylic acid resin claim 3 , a polyolefin resin or a copolymer of any combination ...

Подробнее
10-10-2013 дата публикации

WEATHER-RESISTANT CROSSLINKED POLYOLEFIN COMPOSITION, POLYOLEFIN SHEET MADE FROM THE SAME AND METHOD FOR MAKING THE SHEET

Номер: US20130267645A1
Принадлежит: NAN YA PLASTICS CORPORATION

A weather-resistant crosslinked polyolefin composition is a novel formula containing a comprehensive mixture constituted by crosslinking agent, antistatic agent, TiOsized in nanometer and TiOsized in micrometer and essential components including polyolefin composition resin, lubricant auxiliary crosslinking agent, antioxidant, UV absorber and filler etc; this novel formula is particularly suited to produce a weather-resistant crosslinked polyolefin sheet with a calender machine instead of an extruder conventionally used, and the polyolefin sheets produced thereof are excellent in both heat-resistant and weather-resistant as well as in a high-quality sheet surface and capably made at a high yield rate through the calender machine. 1. A weather-resistant crosslinked polyolefin composition , suitably processed by a calender machine to produce a weather-resistant crosslinked polyolefin sheet , comprising: 20-50 PHR of polyethylene (PE),', '30-60 PHR of polypropylene (PP), and', '0.1-30 PHR of an ethylene-vinyl acetate (EVA) copolymer having a vinyl acetate (VA) content of 8-33%;, '100 PHR (parts per hundred resin) of a polyolefin composition resin comprising{'sub': 2', '2, '0.1-35 PHR of a comprehensive mixture comprising, based on a total comprehensive mixture weight thereof, 0.1-3 wt % of a main crosslinking agent, 0.1-1.5 wt % of an antistatic agent, 0.1-1.5 wt % of TiOnanoparticles and 94-99.7 wt % of TiOmicroparticles;'}0.01-2 PHR of an auxiliary crosslinking agent;0.1-15 PHR of a lubricant;0.1-5 PHR of an antioxidant;0.1-3 PHR of a UV absorber;0.1-30 PHR of a filler; and0-35 PHR of a colorant, if any.2. A method for producing a weather-resistant crosslinked polyolefin sheet produced through a calender machine , comprising the steps of:{'sub': 2', '2, '1) adding 0.1-3 wt % of a main crosslinking agent, 0.1-1.5 wt % of an antistatic agent, 0.1-1.5 wt % of TiOnanoparticles and 94-99.7 wt % of TiOmicroparticles, and mixing aforesaid ingredients evenly in a kneader at ...

Подробнее
31-10-2013 дата публикации

SULFOALKYL ETHER CYCLODEXTRIN COMPOSITIONS AND METHODS OF PREPARATION THEREOF

Номер: US20130288054A1
Принадлежит:

A particulate SAE-CD composition is provided. The SAE-CD composition has an advantageous combination of physical properties not found in known solid forms of SAE-CD. In particular, the SAE-CD composition possesses an advantageous physicochemical and morphological property profile such that it can be tailored to particular uses. The SAE-CD composition of the invention has improved flow and dissolution performance as compared to known compositions of SAE-CD. 1. A composition comprising a sulfoalkyl ether cyclodextrin composition , wherein the sulfoalkyl ether cyclodextrin composition has:a. a moisture content below the point of deliquescence of the sulfoalkyl ether cyclodextrin composition;{'sup': '3', 'b. a bulk density in the range of about 0.55 to about 0.66 g/cm; and'}{'sup': '3', 'c. a tapped density in the range of about 0.66 to about 0.75 g/cm.'}2. The composition of claim 1 , wherein the sulfoalkyl ether cyclodextrin composition has a moisture content of less than about 18% by wt.3. The composition of claim 1 , wherein the sulfoalkyl ether cyclodextrin composition has a true density in the range of about 1.1 to 1.5 g/cm.4. The composition of claim 1 , wherein the sulfoalkyl ether cyclodextrin composition has a CARR's index of less than or about 24%.5. The composition of claim 1 , wherein the sulfoalkyl ether cyclodextrin composition has a gravitational-flow minimum orifice diameter of less than about 20 mm.6. The composition of claim 1 , wherein the sulfoalkyl ether cyclodextrin composition has been prepared by fluidized bed spray drying.7. The composition of claim 1 , wherein the sulfoalkyl ether cyclodextrin composition comprises agglomerated particles.8. The composition of claim 7 , wherein the agglomerated particles have a mean particle diameter less than or equal to 110 microns.9. The composition of claim 7 , wherein the agglomerated particles have a mean particle diameter of 92 to 200 microns.10. The composition of claim 1 , wherein the sulfoalkyl ether ...

Подробнее
07-11-2013 дата публикации

Method for producing pseudopolyrotaxane

Номер: US20130296546A1

The present invention aims to provide an industrially advantageous method of producing a powdery pseudopolyrotaxane with a high inclusion ratio. The present invention relates to a method for producing a pseudopolyrotaxane, including: an inclusion step of mixing a polyethylene glycol and a cyclodextrin in an aqueous medium to form an aqueous dispersion of pseudopolyrotaxane that contains pseudopolyrotaxane particles in which the polyethylene glycol is included in the cavities of the cyclodextrin molecules in a skewered manner; and a drying step of drying the aqueous dispersion of pseudopolyrotaxane produced in the inclusion step to obtain the pseudopolyrotaxane. In the drying step, the aqueous dispersion of pseudopolyrotaxane is sprayed and dried in a heated gas-stream.

Подробнее
28-11-2013 дата публикации

METHODS AND SYSTEMS FOR POLYMER PRECIPITATION AND GENERATION OF PARTICLES

Номер: US20130317208A1
Принадлежит: CERULEAN PHARMA INC.

Processes for precipitating a polymer from a polymer-containing fluid are disclosed, which include providing a vessel housing a medium that provides one or more precipitation surfaces. A polymer-containing fluid, e.g., a polymer solution, dispersion or mixed solution/dispersion, and an anti-solvent can be introduced into the vessel so as to cause precipitation of at least a portion of the polymer on at least one of the precipitation surfaces. In some embodiments, the polymer contains one or more cyclic oligosaccharide moieties, such as one or more cyclodextrin moieties (e.g., α-cyclodextrin, β-cyclodextrin, and γ-cyclodextrin). The polymer can be any of a linear or branched polymer. The polymer can be any of polycation, a polyanion, or a non-ionic polymer. Also disclosed herein are precipitation surfaces with polymer precipitated thereon. 1. A process for precipitating a polymer from a polymer-containing fluid , comprising:providing a vessel housing a medium, the medium providing one or more precipitation surfaces,introducing a polymer-containing fluid and an anti-solvent into the vessel so as to cause precipitation of at least a portion of the polymer on at least one of said precipitation surfaces,wherein the polymer contains one or more cyclic oligosaccharide moieties.2. The process of wherein the process further comprises extracting at least a portion of the polymer-containing fluid and the anti-solvent from the vessel and recirculating the mixture thorough the vessel and medium to induce further precipitation.3. The process of claim 1 , wherein said medium is porous.4. (canceled)5. The process of claim 3 , wherein said porous medium comprises a plurality of insoluble supports providing said precipitation surfaces.611-. (canceled)12. The process of claim 5 , wherein said insoluble supports having said precipitation surfaces comprise a powder of diatomaceous earth.13. The process of claim 1 , wherein said medium is inert to any of said anti-solvent claim 1 , said ...

Подробнее
12-12-2013 дата публикации

Multi-Layer Films And Methods Of Forming Same

Номер: US20130327476A1
Принадлежит: The Procter & Gamble Company

A multi-layer film having a first film layer being at least partially formed from a polymer (A) and a polymer (B) and a second film layer being at least partially formed from the polymer (A), the polymer (B), a polymer (C), and optionally an opacifying agent, wherein at least one of the polymer (A), the polymer (B) and the polymer (C) is synthetic and is at least partially derived from a renewable resource such that the multi-layer film has a bio-based content of about 10% to about 100% using ASTM D6866-10, method B. Methods of forming multi-layer films are also provided. 1. A method , of forming a multi-layer film , comprising:a. providing a renewable resource that is a natural resource that can be replenished within a 100 year time frame;b. deriving a monomer from the renewable resource and polymerizing the monomer to form a synthetic polymer;c. forming at least one of polymer (A), polymer (B) and polymer (C) from the synthetic polymer;d. processing a first film layer having an upper surface and a lower surface, the first film layer being at least partially formed from a polymer (A) and a polymer (B), wherein the first film layer comprises from about 75% to about 99% by weight of the polymer (A) and from about 1% to about 25% by weight of the polymer (B), wherein the polymer (A) comprises at least one of a low density polyethylene (LDPE) and a linear low density polyethylene (LLDPE) and the polymer (B) comprises a copolymer;e. processing a second film layer that is at least partially formed from polymer (A), polymer (B), from about 1% to about 35% by weight of a polymer (C), and optionally an opacifying agent, wherein polymer (C) comprises a homo polypropylene (homo-PP), and wherein at least one of polymer (A), polymer (B) and polymer (C) comprises the synthetic polymer to provide the multi-layer film having a bio-based content of about 10% to about 100% using ASTM D6866-10, method B; andf. at least partially overlying the second film layer onto one of the upper ...

Подробнее
12-12-2013 дата публикации

NUTRITIONAL COMPOSITIONS COMPRISING CHITIN MICROPARTICLES

Номер: US20130330413A1
Автор: MacKenzie Neill Moray
Принадлежит: CMP THERAPEUTICS LIMITED

Nutritional oral compositions are disclosed that contain a nutritional component, such as a macronutrient or a micronutrient. The nutritional compositions also include a chitin microparticle preparation preferably obtained by microfluidisation, wherein the chitin microparticles have an average diameter of between 1 and 100 μm. 1. An oral nutritional composition , the composition comprising one or more nutritional components and a chitin microparticle preparation (CMP) , wherein the chitin microparticles have an average diameter of between 1 and 100 μm and are obtainable by microfluidisation.2. The oral nutritional composition according to claim 1 , wherein the chitin microparticles obtainable by microfluidisation have at least one of the following properties:(a) the chitin microparticles form a stable aqueous suspension at a concentration of 5 mg/ml and a temperature of 25° C. for at least one hour;(b) the chitin microparticles have a gel-like consistency in aqueous compositions; and(c) the chitin microparticles have a fluffy shape in contrast to the angular spheroid chitin microparticles produced by sonication.3. The oral nutritional composition according to claim 1 , wherein the composition is a nutritionally complete formulation or a supplementary formulation.4. The oral nutritional composition according to claim 1 , wherein the composition is a nutritional composition for enteral adsorption.5. The oral nutritional composition according to claim 4 , wherein at least one nutritional component is a macronutrient.6. The oral nutritional composition according to claim 4 , wherein the composition includes two or more nutritional components selected from the group of macronutrients of protein claim 4 , carbohydrate and lipid.7. The oral nutritional composition according to claim 4 , wherein at least one nutritional component is a micronutrient.8. The oral nutritional composition according to claim 7 , wherein the composition includes two or more nutritional components ...

Подробнее
19-12-2013 дата публикации

DURABLE HAEMOSTATIC SCAFFOLD

Номер: US20130338073A1
Принадлежит:

A haemostatic and adhesive durable scaffold useful for promoting wound healing is provided. A scaffold made of fibrinogen and chitosan is produced by electrospinning techniques, resulting in a material with enhanced endurance, applicable in various medical purposes including surgery, tissue regeneration, burns, injuries, etc. Scaffold is produced in the absence of biocatalysts, in particular thrombin. 1. A durable haemostatic scaffold with enhanced bioadhesivity comprising simultaneously electrospun fibrinogen and/or fibrin , and chitosan.2. The scaffold of comprising fibres of electrospun fibrinogen and/or fibrin and chitosan claim 1 , whereas said fibres are exposed to the inner and outer surface of said scaffold claim 1 , and gaps of size sufficient for eukaryotic cells to attach and proliferate.3. The scaffold of characterized in that said scaffold is produced by simultaneous electrospinning of fibrinogen/fibrin solution and chitosan solution in the absence of biocatalysts enabling the polymerization reaction of fibrinogen into fibrin claim 1 , in particular thrombin.4. The scaffold of claim 1 , wherein the solvents of fibrinogen and chitosan are halogenated alcohol(s) and halogenated acid(s).5. The scaffold of claim 1 , wherein the solvent of fibrinogen is hexafluoropropanol/trifluoroacetic acid (90:10) and the solvent of chitosan is trifluoroacetic acid.6. The scaffold of claim 1 , wherein electrospinning is performed at the voltage biases from 5 to 30 kV claim 1 , preferably at 10 kV.7. (canceled)8. (canceled)9. (canceled) This invention relates to medicine, in particular to materials useful for tissue regeneration and haemostatic compositions in the prevention of blood loss from injuries, surgical procedures and traumatic wounds.Tissue engineering and wound healing have been quickly evolving interdisciplinary areas which have been of great interest for decades. Ideally wound healing products should be safe (low immunogenicity, free from infectious agents ...

Подробнее
23-01-2014 дата публикации

COMPOSITIONS AND METHODS FOR PREVENTING INFECTIOUS DISEASES IN FEMALES

Номер: US20140024615A1
Принадлежит:

A product that includes a bioadhesive treatment solution for prevention of infectious diseases in the urinary tract of a female is provided. The product includes a polysaccharide. The product is positioned over the urinary tract of a female to act as a barrier against infectious transfer. A method for applying the product and a method for making the product are also disclosed. 1. A method of providing preventative care to a female for reducing infectious disease , the method comprising applying one of a bioadhesive and mucosadhesive material to either the urethral opening or periurethral area of a female.2. The method according to claim 1 , wherein applying a bioadhesive material comprises applying a bioadhesive gel to prevent a urinary tract infection of the female.3. The method according to claim 2 , wherein the bioadhesive gel exhibits adhesive properties at or above 98 degrees Fahrenheit.4. The method according to claim 2 , wherein the bioadhesive gel further comprises an antimicrobial agent.5. The method according to claim 4 , wherein the antimicrobial is an inorganic ion releasing material.6. The method according to claim 2 , wherein the bioadhesive material comprises chitosan.7. The method according to claim 6 , wherein the chitosan is at least 80% deacetylated.8. The method according to claim 6 , wherein the bioadhesive material comprises between 2.5% and 6% by weight of chitosan.9. The method according to claim 8 , wherein the bioadhesive material comprises between 1% and 7% by volume of lactic acid.10. The method according to claim 1 , wherein the bioadhesive material comprises a high molecular weight polysaccharide.11. The method according to claim 2 , wherein the bioadhesive material comprises an acidic solvent12. The method according to claim 11 , wherein the acid solution is one of acetic acid and lactic acid.13. The method according to claim 12 , wherein the bioadhesive material comprises between 1% and 18% by volume of alcohol.14. The method ...

Подробнее
23-01-2014 дата публикации

TRANSPARENT RESIN COMPOSITION

Номер: US20140024782A1
Принадлежит: LG CHEM, LTD.

The present invention relates to a transparent resin composition which comprises (a) a (meth)acrylate based resin comprising one or more (meth)acrylate based derivatives; and (b) an aromatic based resin having a chain having the hydroxy group containing portion and an aromatic moiety. 115-. (canceled)16. A method for manufacturing an optical film , the method comprising the steps of:preparing the a resin composition comprising(a) a copolymer comprising 50 to 99% by weight of a (meth)acrylate based unit and 1 to 50% by weight of a cyclic based unit having a cyclic portion derived from N-cyclohexylmaleimide and(b) an aromatic based resin having a chain having the hydroxy group containing portion and an aromatic moiety; andshaping the film by using the resin composition,wherein a haze value of the optical film is 2.5% or less.17. The method for manufacturing an optical film as set forth in claim 16 , further comprising:uniaxially or biaxially stretching the film.19. The method for manufacturing an optical film as set forth in claim 18 , further comprising:uniaxially or biaxially stretching the film.20. The method for manufacturing an optical film as set forth in claim 16 , wherein the (meth)acrylate based unit is selected from the group consisting of methyl methacrylate claim 16 , methyl acrylate claim 16 , ethyl acrylate claim 16 , butyl acrylate claim 16 , 2-ethylhexyl methacrylate claim 16 , lauryl methacrylate and benzyl methacrylate.21. The method for manufacturing an optical film as set forth in claim 16 , wherein the aromatic based resin includes a phenoxy based resin.22. The method for manufacturing an optical film as set forth in claim 21 , wherein the aromatic based resin has a number average molecular weight in the range of 1 claim 21 ,500 to 2 claim 21 ,000 claim 21 ,000 g/mol.26. The method for manufacturing an optical film as set forth in claim 16 , wherein the resin composition has a single glass transition temperature.27. The method for manufacturing an ...

Подробнее
27-02-2014 дата публикации

POLYROTAXANE COMPOSITION

Номер: US20140058078A1
Принадлежит:

The present invention aims to provide a polyrotaxane composition having excellent storage stability. The present invention relates to a polyrotaxane composition comprising: a polyrotaxane containing a cyclodextrin, a polyethylene glycol which is included in the cavities of the cyclodextrin molecules in a skewered manner, and a capping group that is placed at each end of the polyethylene glycol and prevents dissociation of the cyclodextrin molecules from the polyethylene glycol; and a polyphenol antioxidant. 1. A polyrotaxane composition comprising:a polyrotaxane containing a cyclodextrin, a polyethylene glycol which is included in the cavities of the cyclodextrin molecules in a skewered manner, and a capping group that is placed at each end of the polyethylene glycol and prevents dissociation of the cyclodextrin molecules from the polyethylene glycol; anda polyphenol antioxidant.2. The polyrotaxane composition according to claim 1 ,wherein the polyethylene glycol has a molecular weight of 1,000 to 500,000.3. The polyrotaxane composition according to claim 1 ,wherein the cyclodextrin is at least one selected from the group consisting of α-cyclodextrin, β-cyclodextrin, and γ-cyclodextrin.4. The polyrotaxane composition according to claim 1 ,which contains the polyrotaxane at an inclusion ratio of 6 to 60%.5. The polyrotaxane composition according to claim 1 ,which contains the polyphenol antioxidant in an amount of 0.001 to 5% by weight, based on the polyrotaxane.6. The polyrotaxane composition according to claim 1 ,wherein the polyphenol antioxidant is at least one selected from the group consisting of rosmarinic acid, gallic acid, catechin, epicatechin, epigallocatechin, epicatechin gallate, and epigallocatechin gallate. The present invention relates to a polyrotaxane composition.“Slide-ring gels”, new gels different from physical gels and chemical gels, have been developed in recent years. A compound that is used for such slide-ring gels and is drawing attention is ...

Подробнее
06-03-2014 дата публикации

OXYGEN BARRIER FOR PACKAGING APPLICATIONS

Номер: US20140065406A1
Принадлежит: KTH Holding AB

The present invention relates to composite material of xyloglucan and clay for use as a coating material. The invention also relates to a method of producing the coating. 1. A coating comprising a layer of a film comprising xyloglucan and clay.2. The coating of wherein the clay is sodium-montmorillonite (MMT).3. The coating according to wherein the clay content is 1 to 30 wt % claim 1 , for example 1 wt % or more claim 1 , or 3 wt % or more claim 1 , or 5 wt % or more claim 1 , or 10 wt % or more claim 1 , or 30 wt % or less claim 1 , or 25 wt % or less or 20 wt % or less claim 1 , or 15 wt % or less claim 1 , or 12 wt % or less.4. The coating according to wherein the clay content is 10-20 wt %.5. The coating according to wherein the sheets of the clay are oriented substantially parallel with the film.6. The coating according to wherein the film does not comprise a plasticizer.7. The coating according to wherein the film consists of xyloglucan and clay.8. The coating according to wherein the coating comprises two or more layers of the film.9. The coating according to wherein the coating has an elastic modulus of at least 6 GPa and a tensile strength of at least 100 MPa when measured at 50% RH at 23° C.10. The coating according to wherein the coating has an oxygen permeability of 0.2 cc.μm/[m2.day]kPa−1 or less when measured at 50% RH at 23° C.11. A paperboard comprising a coating of .12. A moulded fiber product comprising a coating of .13. A polymeric material comprising a coating of .14. The coated polymeric material of wherein the polymer is a polyester.15. The coated polymeric material of wherein the polymer is an oriented polyester.16. A film comprising xyloglucan and 20 wt % of clay.17. A method of coating a substrate with the coating of comprising the steps:a. Providing a substrate;b. Optionally activating the surface of the substrate;c. Providing a dispersion of xyloglucan and clay;d. Applying the dispersion to the substrate;e. Spreading the dispersion across ...

Подробнее
06-03-2014 дата публикации

PRODUCTION METHOD FOR POWDERED HYDROPHILIC MODIFIED POLYROTAXANE

Номер: US20140066615A1
Принадлежит:

The present invention aims to provide a method of producing a powdered hydrophilic modified polyrotaxane, which enables production of a powdered hydrophilic modified polyrotaxane excellent in storage stability in an industrially advantageous way. The present invention provides a method of producing a powdered hydrophilic modified polyrotaxane, comprising: a hydrophilic modification step of preparing a solution of a hydrophilic modified polyrotaxane by modifying all or part of hydroxy groups on a cyclodextrin of a polyrotaxane with hydrophilic modifying groups, the polyrotaxane containing the cyclodextrin, a polyethylene glycol included in the cavities of the cyclodextrin molecules in a skewered manner, and a capping group that is placed at each end of the polyethylene glycol and prevents dissociation of the cyclodextrin molecules from the polyethylene glycol; and a drying step of spraying the prepared solution of the hydrophilic modified polyrotaxane and drying the solution of the hydrophilic modified polyrotaxane in a heated gas stream. 1. A method of producing a powdered hydrophilic modified polyrotaxane , comprising:a hydrophilic modification step of preparing a solution of a hydrophilic modified polyrotaxane by modifying all or part of hydroxy groups on a cyclodextrin of a polyrotaxane with hydrophilic modifying groups, the polyrotaxane containing the cyclodextrin, a polyethylene glycol included in the cavities of the cyclodextrin molecules in a skewered manner, and a capping group that is placed at each end of the polyethylene glycol and prevents dissociation of the cyclodextrin molecules from the polyethylene glycol; anda drying step of spraying the prepared solution of the hydrophilic modified polyrotaxane and drying the solution of the hydrophilic modified polyrotaxane in a heated gas stream.2. The method of producing a powdered hydrophilic modified polyrotaxane according to claim 1 ,wherein the polyethylene glycol has a weight average molecular weight of 1, ...

Подробнее
06-03-2014 дата публикации

PRODUCTION METHOD FOR HYDROPHILIC MODIFIED POLYROTAXANE

Номер: US20140066616A1
Принадлежит:

The present invention aims to provide a method of producing a hydrophilic modified polyrotaxane, which enables production of a hydrophilic modified polyrotaxane excellent in storage stability in an industrially advantageous way. The present invention provides a method of producing a hydrophilic modified polyrotaxane, comprising: a hydrophilic modification step of preparing a solution of a hydrophilic modified polyrotaxane by modifying all or part of hydroxy groups on a cyclodextrin of a polyrotaxane with hydrophilic modifying groups, the polyrotaxane containing the cyclodextrin, a polyethylene glycol included in the cavities of the cyclodextrin molecules in a skewered manner, and a capping group that is placed at each end of the polyethylene glycol and prevents dissociation of the cyclodextrin molecules from the polyethylene glycol; and a drying step in which the prepared solution of the hydrophilic modified polyrotaxane is formed into a thin film state and dried. 1. A method of producing a hydrophilic modified polyrotaxane , comprising:a hydrophilic modification step of preparing a solution of a hydrophilic modified polyrotaxane by modifying all or part of hydroxy groups on a cyclodextrin of a polyrotaxane with hydrophilic modifying groups, the polyrotaxane containing the cyclodextrin, a polyethylene glycol included in the cavities of the cyclodextrin molecules in a skewered manner, and a capping group that is placed at each end of the polyethylene glycol and prevents dissociation of the cyclodextrin molecules from the polyethylene glycol; anda drying step in which the prepared solution of the hydrophilic modified polyrotaxane is formed into a thin film state and dried.2. The method of producing a hydrophilic modified polyrotaxane according to claim 1 ,wherein the polyethylene glycol has a weight average molecular weight of 1,000 to 500,000.3. The method of producing a hydrophilic modified polyrotaxane according to claim 1 ,wherein the drying step is carried out at ...

Подробнее
13-03-2014 дата публикации

METHOD FOR TREATING THE EAR, NOSE OR THROAT

Номер: US20140073601A1
Принадлежит: Medtronic, Inc.

Bodily tissue and structures may be protected using a fluid layer containing a mixture of chitosan and oxidized polysaccharide. The mixture forms a protective gel layer via in situ crosslinking. Compared to crosslinking using a low molecular weight aldehyde such as glutaraldehyde or genipin, oxidized polysaccharides appear to provide faster gelation while avoiding the use of potentially less bioacceptable low molecular weight aldehydes. 111-. (canceled)12. A method for treating bodily tissue or structure in the ear , nose or throat , which method comprises:a) applying to such ear, nose or throat tissue or structure a fluid layer containing a mixture of chitosan and an oxidized polysaccharide, andb) allowing the mixture to form a protective gel layer in situ.13. A method according to comprising applying the fluid layer to a nasal or sinus cavity.14. A method according to comprising applying the fluid layer to a middle or inner ear.15. A method according to comprising applying the fluid layer to throat tissue.16. A method according to comprising applying the fluid layer to mucosal tissue.17. A method according to comprising applying the fluid layer from a multiple-barrel syringe.18. A method according to comprising applying the fluid layer by spraying.19. A method according to wherein the chitosan is an unmodified chitosan or a chitosan salt.20. A method according to wherein the chitosan is a chitosan derivative.21. A method according to wherein the oxidized polysaccharide comprises oxidized starch.22. A method according to wherein the oxidized polysaccharide comprises oxidized cellulose.23. A method according to wherein the oxidized polysaccharide comprises oxidized chitin claim 12 , oxidized chitosan claim 12 , oxidized chondroitin sulfate claim 12 , oxidized dextran claim 12 , oxidized glycogen or oxidized hyaluronic acid.24. A method according to wherein the chitosan and oxidized polysaccharide are combined in a ratio of about 10:1 to about 1:20.25. A method ...

Подробнее
20-03-2014 дата публикации

HARD COATING FILM

Номер: US20140079937A1
Принадлежит: LG CHEM, LTD.

The present invention relates to a hard coating film including a hard coating layer comprising: a crosslinked product of (a) a polyrotaxane compound including a macrocycle to which a lactone-based compound is bonded, wherein a (meth)acrylate-based compound is introduced at the end of the lactone-based compound at a ratio of 40 mol % to 70 mol %, a linear molecule penetrating the macrocycle, and blocking groups arranged at both ends of the linear molecule and preventing the macrocycle from escaping; and (b) a binder resin. 1. A hard coating film comprising a hard coating layer comprising: a crosslinked product of (a) a polyrotaxane compound comprising a macrocycle to which a lactone-based compound is bonded , wherein a (meth)acrylate-based compound is introduced at the end of the lactone-based compound at a ratio of 40 mol % to 70 mol % , a linear molecule penetrating the macrocycle , and blocking groups arranged at both ends of the linear molecule and preventing the macrocycle from escaping; and (b) a binder resin.2. The hard coating film according to claim 1 ,wherein a ratio of the (meth)acrylate-based compound introduced at the end of the lactone-based compound is 45 mol % to 65 mol %.3. The hard coating film according to claim 1 ,wherein the macrocycle includes at least one selected from the group consisting of α-cyclodextrin, β-cyclodextrin, and γ-cyclodextrin.4. The hard coating film according to claim 1 ,wherein the lactone-based compound is bonded to the macrocycle by a direct bond or a C1-10 linear or branched oxyalkylene group.6. The hard coating film according to claim 1 ,wherein the (meth)acrylate-based compound is bonded to the residue of the lactone-based compound through a direct bond, a urethane bond, an ether bond, a thioester bond, or an ester bond.8. The hard coating film according to claim 1 ,wherein the linear molecule is a polyoxyalkylene-based compound or a polylactone-based compound.9. The hard coating film according to claim 1 ,wherein the ...

Подробнее
20-03-2014 дата публикации

Composites Comprising a Polymer and a Layered Compound and Methods of Preparing and Using Same

Номер: US20140080958A1
Автор: Sosa Jose, Sun Luyi
Принадлежит: FINA TECHNOLOGY, INC.

A method comprising extrusion compounding a styrenic polymer and a layered compound to produce a composite, and orienting the composite to produce an oriented composite wherein the layered compound comprises natural clay, synthetic clay, natural colloid, synthetic colloid, natural sol, synthetic sol, natural gel, synthetic gel, natural fumes, synthetic fumes, or combinations thereof. A method of preparing an oriented film comprising extrusion compounding a styrenic polymer and a clay to produce a nanocomposite, casting the nanocomposite into a film, and orienting the film in at least one direction. 119-. (canceled)20. A method of preparing an oriented film comprising:extrusion compounding a styrenic polymer and a clay to produce a nanocomposite;casting the nanocomposite into a film; andorienting the film in at least one direction.21. The method of claim 20 , wherein the styrenic polymer is present in an amount of from 50% to 99.9% by weight of the nanocomposite claim 20 , and wherein the clay is present in an amount of from 0.1% to 50% by weight of the nanocomposite.22. The method of claim 20 , wherein the styrenic polymer comprises substituted styrenes claim 20 , alpha-methyl styrene claim 20 , ring-substituted styrenes claim 20 , p-methylstyrene claim 20 , disubstituted styrenes claim 20 , p-t-butyl styrene claim 20 , unsubstituted styrenes claim 20 , halogenated styrenes claim 20 , alkylated styrenes claim 20 , acrylonitrile claim 20 , esters of methacrylic acid with alcohols having from 1 to 8 carbons claim 20 , N-vinyl compounds claim 20 , vinylcarbazole claim 20 , maleic anhydride claim 20 , compounds which contain two polymerizable double bonds claim 20 , divinylbenzene claim 20 , butanediol diacrylate claim 20 , or combinations thereof; and the clay comprises natural clay claim 20 , synthetic clay claim 20 , natural colloid claim 20 , synthetic colloid claim 20 , natural sol claim 20 , synthetic sol claim 20 , natural gel claim 20 , synthetic gel claim 20 , ...

Подробнее
27-03-2014 дата публикации

FILMS AND MEMBRANES OF POLY (ARYL KETONES) AND METHODS OF CASTING THE SAME FROM SOLUTION

Номер: US20140088234A1
Принадлежит:

A method of manufacturing a film or membrane includes: (a) dissolving at least one polymer comprising a poly(aryl ketone) in at least one solvent to form a dope; (b) depositing the dope on a substrate to form a coated substrate at appropriate conditions; and (c) drying the coated substrate to form the film or membrane. The dope may also include additional polymers or fillers, such as carbon nanotubes. 1. A method of manufacturing a film or membrane comprising;dissolving at least one polymer comprising a poly(aryl ketone) in at least one solvent to form a dope; depositing the dope on a substrate to form a coated substrate; and drying the coated substrate to form the film or membrane.2. A method of manufacturing a film or membrane according to claim 1 , wherein the at least one polymer comprises one or more poly(aryl ketones) selected from polyetherketoneketones (PEKK) claim 1 , polyetheretherketones (PEEK) claim 1 , polyetherketones (PEK) claim 1 , polyetherketoneetherketoneketones (PEKEKK) claim 1 , or mixtures thereof.3. A method of manufacturing a film or membrane according to claim 2 , wherein the poly(aryl ketone) comprises PEKK.4. A method of manufacturing a film or membrane according to claim 1 , wherein the at least one solvent comprises a halogenated organic compound.5. A method of manufacturing a film or membrane according to claim 1 , wherein the at least one solvent comprises a halogenated organic acid.6. A method of manufacturing a film or membrane according to claim 1 , wherein the at least one solvent comprises a chlorinated organic acid.7. A method of manufacturing a film or membrane according to claim 1 , wherein the at least one solvent comprises an aromatic solvent.8. A method of manufacturing a film or membrane according to claim 1 , wherein the at least one solvent has a boiling point at atmospheric pressure of not greater than 250° C.9. A method of manufacturing a film or membrane according to claim 1 , wherein the at least one solvent comprises ...

Подробнее
03-04-2014 дата публикации

POLYMERIC FILM OR COATING COMPRISING HEMICELLULOSE

Номер: US20140093724A1
Принадлежит: XYLOPHANE AB

A film forming composition and a polymeric film or coating comprising hemicellulose is disclosed, said polymeric film or coating further comprising at least one additive/reactant increasing the liquid/moisture resistance. The use of said film or coating is also disclosed. Further, a method for the manufacture of said polymeric film or coating is disclosed, as well as a method for improving the liquid/moisture resistance of hemicellulose. The hemicellulose/phyllosilicate nanocomposite reinforced material provides excellent liquid/moisture resistance. 1. A liquid/moisture resistant polymeric film or coating comprising:hemicellulose extracted from biomass;at least one component to improve film formability, the component comprising at least one plasticizer in an amount between 20% and 50%, by weight, of the combined weight of the hemicellulose and plasticizer; andbetween 0.1% and 15% by weight of at least one agent to increase the liquid/moisture resistance of the film or coating, the agent comprising a layered phyllosilicate.2. A liquid/moisture resistant polymeric film or coating as claimed in claim 1 , wherein said at least one agent includes a hydrophobizing agent.3. A liquid/moisture resistant polymeric film or coating as claimed in claim 2 , wherein said film or coating has:a hemicellulose content in % by dry weight 60-90%,a cross-linking agent andthe hydrophobizing agent is, in % by dry weight, of 0-5%.4. A liquid/moisture resistant polymeric film or coating as claimed in claim 1 , further comprising at least one of citric acid claim 1 , boric acid claim 1 , polyamidoamine-epichlorohydrin claim 1 , ethylene acrylic acid copolymer claim 1 , formaldehyde claim 1 , glyoxal claim 1 , epichlorohydrin claim 1 , phosphoric acid and acrolein.5. A liquid/moisture resistant polymeric film or coating as claimed in claim 1 , further comprising at least one of an acid anhydride claim 1 , a rosin claim 1 , an alkenyl succinic anhydride claim 1 , and an alkyl keten dimer.6. A ...

Подробнее
07-01-2021 дата публикации

Pharmaceutical compositions comprising meloxicam

Номер: US20210000956A1
Автор: Herriot Tabuteau

Disclosed herein are compositions comprising an NSAID such as meloxicam and/or rizatriptan in combination with a cyclodextrin and/or a carbonate or a bicarbonate. These compositions may be orally administered, for example, to improve the bioavailability or pharmacokinetics of the NSAID for the treatment of pain such as migraine, arthritis, and other conditions. Also disclosed herein are methods of treating pain, such as migraine, comprising administering meloxicam and rizatriptan to a human being suffering from pain, such as migraine. For migraine, these methods may be particularly useful when the meloxicam and rizatriptan are administered while the human being is suffering from an acute attack of migraine pain or migraine aura. In some embodiments, the combination of meloxicam and rizatriptan may be administered in a manner that results in a Tmax of meloxicam of 3 hours or less.

Подробнее
06-01-2022 дата публикации

BENDABLE CIRCUIT BOARD, EXPANDABLE CIRCUIT BOARD, AND ELECTRONIC DEVICE MADE THEREFROM

Номер: US20220002507A1
Принадлежит:

Provided are an expandable or bendable circuit board having good body-contact feel, strong against bending and folding, and an electronic device made therefrom. The bendable circuit board includes: a film comprising a polyurethane synthesized by reacting a long-chain polyol with polyisocyanate and having a storage modulus at ° C. of to MPa, a tensile strength of to MPa, and an elongation at break of to %, and the temperature of which the storage elastic modulus reaches to MPa is at ° C. or higher; and circuit wiring formed in contact with a surface of the film. Alternatively, an expandable circuit board having the ratio ρ/ρof the specific electrical resistance ρ of the circuit wiring when the circuit wiring is expanded to the specific electrical resistance (Ω·cm) ρof the circuit wiring before the circuit wiring is expanded is within a range of to 1. A bendable wiring board , comprising:a film composed of a polyurethane to be synthesized by allowing a long-chain polyol to react with a polyisocyanate, whereina temperature of the polyurethane at which a storage elastic modulus measured by a dynamic viscoelasticity measurement becomes 1 MPa is 155° C. or higher, and the storage elastic modulus of 20 to 200 MPa at 25° C.,', 'a tensile strength of 20 to 80 MPa, and', 'elongation at break of 500 to 900%; and, 'the polyurethane has'}circuit wiring formed so as to be in contact with a surface of the film.2. The bendable wiring board according to claim 1 , wherein the polyisocyanate has a constituent unit derived from 1 claim 1 ,4-bis(isocyanatomethyl)cyclohexane with a trans isomer at a proportion of 70% to 95%.3. The bendable wiring board according to claim 1 , wherein the long-chain polyol has a number average molecular weight of 500 to 3 claim 1 ,500.4. The bendable wiring board according to claim 1 , wherein the polyurethane is a thermoplastic polyurethane claim 1 , and the film is a single-layer film.5. An elastic (stretchable and shrinkable) wiring board claim 1 , ...

Подробнее
06-01-2022 дата публикации

HYDROPHILIC COATING COMPOSITION FOR DUAL COATING AND HYDROPHILIC COATING METHOD USING SAME

Номер: US20220002572A1
Автор: CHOI Hyung Joon
Принадлежит:

A hydrophilic coating composition and a hydrophilic coating method using the same are disclosed. The hydrophilic coating composition can include a first coating solution, a second coating solution, and a crosslinking agent. The first coating solution includes a polyurethane-based compound, and the second coating solution includes a polysaccharide. The coating composition can provide a coating that is strongly hydrophilic, highly biocompatible, thin, and flexible. Thus, when the coating composition is applied to an invasive medical device, lubricity can be greatly increased, thereby preventing damage to the human body, such as injury, tissue abrasion and the like. 1. A hydrophilic coating composition , comprising:a first coating solution comprising a polyurethane-based compound;a second coating solution comprising a polysaccharide; anda crosslinking agent configured to link the first and second coating solutions.2. The hydrophilic coating composition of claim 1 , wherein the crosslinking agent is configured to bind the first coating solution to a substrate claim 1 , and bind the second coating solution to the first coating solution.3. The hydrophilic coating composition of claim 1 , wherein the composition is biocompatible.4. The hydrophilic coating composition of claim 1 , wherein the polyurethane-based compound comprises polyether polyurethane.5. The hydrophilic coating composition of claim 1 , wherein the polysaccharide comprises hyaluronic acid.6. The hydrophilic coating composition of claim 1 , wherein the crosslinking agent comprises a polyaziridine-based crosslinking agent or a polyisocyanate-based crosslinking agent.7. The hydrophilic coating composition of claim 1 , wherein the second coating solution further comprises polyether polyurethane.8. The hydrophilic coating composition of claim 7 , wherein a weight ratio of the polysaccharide to the polyether polyurethane is about 10:0.5-2.9. A hydrophilic coating method claim 7 , comprising:first coating a ...

Подробнее
02-01-2020 дата публикации

PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM

Номер: US20200000919A1
Автор: Tabuteau Herriot
Принадлежит:

Disclosed herein are compositions comprising an NSAID such as meloxicam and/or rizatriptan in combination with a cyclodextrin and/or a carbonate or a bicarbonate. These compositions may be orally administered, for example, to improve the bioavailability or pharmacokinetics of the NSAID for the treatment of pain such as migraine, arthritis, and other conditions. Also disclosed herein are methods of treating pain, such as migraine, comprising administering meloxicam and rizatriptan to a human being suffering from pain, such as migraine. For migraine, these methods may be particularly useful when the meloxicam and rizatriptan are administered while the human being is suffering from an acute attack of migraine pain or migraine aura. In some embodiments, the combination of meloxicam and rizatriptan may be administered in a manner that results in a Tof meloxicam of 3 hours or less. 1. A method of treating migraine comprising: selecting a human migraine patient with a history of inadequate response to prior migraine treatments , and orally administering a solid dosage form to the migraine patient , wherein the solid oral dosage form comprises a combination of: 1) a complex of meloxicam with a sulfobutyl ether β-cyclodextrin (SBEβCD) , 2) a bicarbonate , and 3) a rizatriptan , wherein the human migraine patient is free of migraine pain two hours after the solid dosage form is orally administered to the human migraine patient.2. The method of claim 1 , wherein the solid oral dosage form contains 400 mg to 600 mg of the bicarbonate.3. The method of claim 1 , wherein the solid oral dosage form contains about 5 mg to about 50 mg of meloxicam.4. The method of claim 1 , wherein the solid oral dosage form contains about 50 mg to about 200 mg of the SBEβCD.5. The method of claim 1 , the solid oral dosage form having a shorter Tof meloxicam in the human being than a reference dosage form that: 1) contains the same amount of meloxicam claim 1 , 2) does not contain an SBEβCD claim 1 , ...

Подробнее
02-01-2020 дата публикации

PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM

Номер: US20200000920A1
Автор: Tabuteau Herriot
Принадлежит:

Disclosed herein are compositions comprising an NSAID such as meloxicam and/or rizatriptan in combination with a cyclodextrin and/or a carbonate or a bicarbonate. These compositions may be orally administered, for example, to improve the bioavailability or pharmacokinetics of the NSAID for the treatment of pain such as migraine, arthritis, and other conditions. Also disclosed herein are methods of treating pain, such as migraine, comprising administering meloxicam and rizatriptan to a human being suffering from pain, such as migraine. For migraine, these methods may be particularly useful when the meloxicam and rizatriptan are administered while the human being is suffering from an acute attack of migraine pain or migraine aura. In some embodiments, the combination of meloxicam and rizatriptan may be administered in a manner that results in a Tof meloxicam of 3 hours or less. 1. A method of treating migraine comprising: selecting a human migraine patient with a history of inadequate response to prior migraine treatments , and orally administering a dosage form to the migraine patient , wherein the dosage form comprises a combination of: 1) a complex of meloxicam with a sulfobutyl ether β-cyclodextrin (SBEβCD) , 2) a bicarbonate , and 3) a rizatriptan , wherein the migraine patient experiences a reduction in nausea as a result of orally administering the dosage form to the migraine patient.2. The method of claim 1 , wherein the dosage form contains 400 mg to 600 mg of the bicarbonate.3. The method of claim 1 , wherein the dosage form contains about 5 mg to about 50 mg of meloxicam.4. The method of claim 1 , wherein the dosage form contains about 50 mg to about 200 mg of the SBEβCD.5. The method of claim 1 , wherein the dosage form is a solid oral dosage form having a shorter Tof meloxicam in the human being than a reference dosage form that: 1) contains the same amount of meloxicam claim 1 , 2) does not contain an SBEβCD claim 1 , and 3) does not contain a ...

Подробнее
02-01-2020 дата публикации

PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM

Номер: US20200000921A1
Автор: Tabuteau Herriot
Принадлежит:

Disclosed herein are compositions comprising an NSAID such as meloxicam and/or rizatriptan in combination with a cyclodextrin and/or a carbonate or a bicarbonate. These compositions may be orally administered, for example, to improve the bioavailability or pharmacokinetics of the NSAID for the treatment of pain such as migraine, arthritis, and other conditions. Also disclosed herein are methods of treating pain, such as migraine, comprising administering meloxicam and rizatriptan to a human being suffering from pain, such as migraine. For migraine, these methods may be particularly useful when the meloxicam and rizatriptan are administered while the human being is suffering from an acute attack of migraine pain or migraine aura. In some embodiments, the combination of meloxicam and rizatriptan may be administered in a manner that results in a Tof meloxicam of 3 hours or less. 1. A method of treating migraine comprising: selecting a human migraine patient with a history of inadequate response to prior migraine treatments , and orally administering a dosage form to the migraine patient , wherein the dosage form comprises a combination of: 1) a complex of meloxicam with a sulfobutyl ether β-cyclodextrin (SBEβCD) , 2) a bicarbonate , and 3) a rizatriptan , wherein the human migraine patient is free of nausea two hours after the dosage form is orally administered to the human migraine patient.2. The method of claim 1 , wherein the dosage form contains 400 mg to 600 mg of the bicarbonate.3. The method of claim 1 , wherein the dosage form contains about 5 mg to about 50 mg of meloxicam.4. The method of claim 1 , wherein the dosage form contains about 50 mg to about 200 mg of the SBEβCD.5. The method of claim 1 , wherein the dosage form is a solid oral dosage form having a shorter Tof meloxicam in the human migraine patient than a reference dosage form that: 1) contains the same amount of meloxicam claim 1 , 2) does not contain an SBEβCD claim 1 , and 3) does not contain a ...

Подробнее
02-01-2020 дата публикации

PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM

Номер: US20200000922A1
Автор: Tabuteau Herriot
Принадлежит:

Disclosed herein are compositions comprising an NSAID such as meloxicam and/or rizatriptan in combination with a cyclodextrin and/or a carbonate or a bicarbonate. These compositions may be orally administered, for example, to improve the bioavailability or pharmacokinetics of the NSAID for the treatment of pain such as migraine, arthritis, and other conditions. Also disclosed herein are methods of treating pain, such as migraine, comprising administering meloxicam and rizatriptan to a human being suffering from pain, such as migraine. For migraine, these methods may be particularly useful when the meloxicam and rizatriptan are administered while the human being is suffering from an acute attack of migraine pain or migraine aura. In some embodiments, the combination of meloxicam and rizatriptan may be administered in a manner that results in a Tof meloxicam of 3 hours or less. 1. A method of treating migraine comprising: selecting a human migraine patient with a history of inadequate response to prior migraine treatments , and orally administering a dosage form to the migraine patient , wherein the dosage form comprises a combination of: 1) a complex of meloxicam with a sulfobutyl ether β-cyclodextrin (SBEβCD) , 2) a bicarbonate , and 3) a rizatriptan , wherein the migraine patient experiences a reduction in phonophobia as a result of orally administering the dosage form to the migraine patient.2. The method of claim 1 , wherein the dosage form contains 400 mg to 600 mg of the bicarbonate.3. The method of claim 1 , wherein the dosage form contains about 5 mg to about 50 mg of meloxicam.4. The method of claim 1 , wherein the dosage form contains about 50 mg to about 200 mg of the SBEβCD.5. The method of claim 1 , wherein the dosage form is a solid oral dosage form having a shorter Tof meloxicam in the human being than a reference dosage form that: 1) contains the same amount of meloxicam claim 1 , 2) does not contain an SBEβCD claim 1 , and 3) does not contain a ...

Подробнее
07-01-2016 дата публикации

CROSS-LINKED POLYMER NETWORKS AND METHODS OF MAKING AND USING SAME

Номер: US20160002421A1
Принадлежит:

Cross-linked polymer networks that are at least partially conjugated (e.g., phenylene vinylene polymer networks). The cross-linked polymer networks may be thin-films disposed on a substrate. The cross-linked polymer network may be covalently bonded to the substrate. The cross-linked polymer networks can be used, for example, in methods of detecting explosives (e.g., RDX (cyclotrimethylenetrinitramine)) and degradation products thereof. 2. The method of claim 1 , wherein the cross-linked polymer network is covalently bonded to the substrate.4. The method of claim 1 , wherein the explosive is selected from nitramines claim 1 , nitroesters claim 1 , degradation products thereof claim 1 , and combinations thereof.5. The method of claim 4 , wherein the nitramine is cyclotrimethylenetrinitramine (RDX) claim 4 , and the nitroester is pentaerythritol tetranitrate (PETN) claim 4 , trinitrotoluene (TNT) claim 4 , dinitrotoluene (DNT) claim 4 , 2 claim 4 ,4 claim 4 ,6-triamino-1 claim 4 ,3 claim 4 ,5-trinitrobenzene (TATB) claim 4 , or 2 claim 4 ,3-dimethyl-2 claim 4 ,3-dinitrobutane (DMNB) claim 4 , octahydro-1 claim 4 ,3 claim 4 ,5 claim 4 ,7-tetranitro-1 claim 4 ,3 claim 4 ,5 claim 4 ,7-tetrazocine (HMX).6. The method of claim 1 , wherein the test sample is a gas-phase sample or a solid sample.7. The method of claim 1 , wherein the sample is not pre-concentrated.8. A thin film of a cross-linked polymer network comprising a plurality of trivinyl benzene moieties disposed on a substrate.9. The thin-film of claim 8 , wherein the substrate is selected from fused silica claim 8 , silicon claim 8 , gold claim 8 , silver claim 8 , platinum claim 8 , copper claim 8 , nickel claim 8 , glass claim 8 , sapphire claim 8 , mica claim 8 , and polymer substrates.10. The thin-film of claim 8 , wherein the cross-linked polymer network is covalently bonded to the substrate.12. The thin film of claim 8 , wherein the film has a thickness of 2 nm to 10 micrometers. This application claims ...

Подробнее
05-01-2017 дата публикации

Asymmetric Regio-regular Conjugated Polymers for Electronic Applications

Номер: US20170002125A1
Принадлежит: 1-MATERIAL INC

A polymer consisting of a regio-regular polymer backbone basing on asymmetric fluorine-substituted 2,1,3-benzothiadiazole units (FBT) having a Formula 1MP0: 4. A film formed from a solvent solution contains the polymer of .5. A device made from a film contains the polymer of . This invention relates to the field of asymmetric regio-regular conjugated polymers and their use in electronic-optical and electronic devices. More particularly, this invention relates to regio-regular conjugated semiconducting polymers containing asymmetric fluorine substituted (2,1,3)-benzothiadiazole in backbone. The invented asymmetric regio-regular conjugated polymers are soluble in common organic solvents for printing thin film devices such as organic photovoltaic devices (OPV), organic photo detectors, organic thin film transistors (OTFT) and organic sensors.Conjugated polymers consist at least of one backbone chain of alternating double and single bonds. The π-electrons in conjugated polymers are delocalized and can be easier moved from one bond to the other, what makes such conjugated polymers to be a kind of organic semiconductors, thus referred as semiconducting polymers as well.Generally, semiconducting polymers are created via cross-coupling condensation reactions with symmetrical monomer units that produce linear polymer backbone configurations. When symmetric monomer units are involved, various regiochemistries between adjacent structural units along the backbone vector can be created. As an example. Scheme-1 demonstrates the possible polymer chain configurations can be generated from monomer 3-hexylthiophene. The electronic properties such as charge mobility in organic thin film transistor (OTFT) and power conversion efficiency (PCE) in organic photovolatic (OPV) devices have been shown to be strongly dependent on the configuration of polymer backbone. Higher performance has been generally observed for these polymers with higher regioregularity. A high regioregularity means a ...

Подробнее
02-01-2020 дата публикации

LIQUID CRYSTAL POLYMER RESIN COMPOSITION FOR OUTER PLATE AND OUTER PLATE

Номер: US20200002485A1
Принадлежит:

A liquid crystal polymer resin composition for an outer plate includes a liquid crystal polymer and a plate-shaped filler, in which the amount of the plate-shaped filler is 20 parts by mass or more and 70 parts by mass or less with respect to 100 parts by mass of the liquid crystal polymer. 1. A liquid crystal polymer resin composition for an outer plate , comprising:a liquid crystal polymer; and a plate-shaped filler,wherein an amount of the plate-shaped filler is 20 parts by mass or more and 70 parts by mass or less with respect to 100 parts by mass of the liquid crystal polymer.2. The liquid crystal polymer resin composition for an outer plate according to claim 1 ,{'sup': '2', 'wherein the composition is used for an outer plate in which a projected area of a maximum surface is 400 cmor more.'}3. The liquid crystal polymer resin composition for an outer plate according to claim 1 ,wherein the composition is used for an outer plate in which an average thickness is 0.03 cm or more and 0.5 cm or less.4. The liquid crystal polymer resin composition for an outer plate according to claim 1 ,{'sup': '2', 'wherein the composition is used for an outer plate in which a ratio of a projected area of a maximum surface (unit: cm) to an average thickness (unit: cm) is 8,000 or more.'}5. An outer plate that is an injection-molded body for which the liquid crystal polymer resin composition for an outer plate according to is used as a forming material.6. An outer plate comprising claim 1 , as forming materials:a liquid crystal polymer; anda plate-shaped filler,wherein an amount of the plate-shaped filler is 20 parts by mass or more and 70 parts by mass or less with respect to 100 parts by mass of the liquid crystal polymer.7. The outer plate according to claim 6 ,{'sup': '2', 'wherein a projected area of a maximum surface is 400 cmor more.'}8. The outer plate according to claim 6 ,wherein an average thickness is 0.03 cm or more and 0.5 cm or less.9. The outer plate according to ...

Подробнее
02-01-2020 дата публикации

BIAXIALLY-STRETCHED FILM AND ETHYLENE POLYMER COMPOSITION

Номер: US20200002490A1
Принадлежит:

Provided is a biaxially-stretched film wherein the biaxial stretching is possible in a broader temperature range and which is excellent in thickness accuracy, and an ethylene polymer composition serving as a raw material of the film. The biaxially-stretched film of the present invention is obtained from an ethylene polymer composition (E) including a specific ethylene polymer component (A) containing 20 to 100 wt % of an ethylene polymer (a) being a copolymer of ethylene and a C4-10 α-olefin and having specific melt flow rate and density, and an ethylene polymer component (B) being another copolymer of ethylene and a C4-10 α-olefin, wherein a weight fraction [W] of the ethylene polymer component (A) is 0.50 or more and 0.92 or less, and a weight fraction [W] of the ethylene polymer component (B) is 0.08 or more and 0.50 or less provided that Wand Wtotal 1.0. 16-. (canceled)7. A biaxially-stretched film obtained from an ethylene polymer composition (E) comprising an ethylene polymer component (A) fulfilling requirements described below and an ethylene polymer component (B) fulfilling requirements described below ,{'sub': A', 'B', 'A', 'B, 'wherein a weight fraction [W] of the ethylene polymer component (A) is 0.50 or more and 0.87 or less, and a weight fraction [W] of the ethylene polymer component (B) is 0.13 or more and 0.50 or less provided that Wand Wtotal 1.0,'}wherein the ethylene polymer component (A) comprises an ethylene polymer (a) described below at 20% by weight or more and 100% by weight or less and fulfills requirements (A-1) to (A-3) described below:{'sub': 'A', '(A-1) Melt flow rate (MFR) at 190° C. under a load of 2.16 kg is not less than 0.1 g/10 min and not more than 3 g/10 min;'}{'sub': 'A', 'sup': 3', '3, '(A-2) Density (D) is 907 kg/mor more and 940 kg/mor less; and'}{'sup': 0.776', '0.776', '−4', '−4, '(A-3) Ratio [η]/Mwof intrinsic viscosity measured in decalin at 135° C. [[η] (dl/g)] to weight average molecular weight measured by GPC- ...

Подробнее
04-01-2018 дата публикации

TRANSPARENT POLYESTER FILM WITH LOW VISIBLE LIGHT TRANSMITTANCE AND HIGH INFRARED-BLOCKING RATE AND METHOD FOR MAKING THE SAME

Номер: US20180002501A1
Принадлежит:

A transparent polyester film has low visible light transmittance of 5-50% by JIS K7705 testing standard and a high infrared-blocking rate of at least 90% by JIS R3106 testing standard, which is extruded from a kind of polyester resins obtained from 5-40 wt % of nanoparticle-based thermal insulation slurry and/or 0.005-0.1 wt % of nanoparticle-based black pigment slurry by weight of and to react with the polymerization materials to completely perform an esterification and a polycondensation, wherein the thermal insulation nanoparticle has a chemical formula of CsNWOClwith an average particle size of 10-90 nm and the nanoparticle-based black contains carbon black particles having a particle size of 20-80 nm. 1. A method for making a transparent polyester film with low visible light transmittance and a high infrared-blocking rate as well as has a common film thickness ranged from 12 to 75 μm , comprising the steps of: [{'sub': X', 'Y', '3-Z', 'C, 'a1) 10-50 wt % of thermal insulation particles, based on the total weight of the thermal insulation slurry; and the thermal insulation particles having a chemical formula of CsNWOClwith an average particle size of 10-90 nm,'}, {'br': None, 'X≦1.0; Y≦1.0; Y/X≦1.0; Z≦0.6, and C≦0.1;'}, 'wherein Cs is cesium; N is tin (Sn), antimony (Sb), or bismuth (Bi); W is tungsten; O is oxygen; and X, Y, Z, and C are positive numbers satisfying the following conditions], 'a) preparing a nanoparticle-based thermal insulation slurry with a viscosity of 50-200 cps, wherein the thermal insulation slurry comprises the following ingredients a1)-a3) to add up to 100% 'a3) 5-40 wt % of a dispersing aid, based on the total weight of the thermal insulation slurry; wherein the dispersing aid is one or more selected from the group consisting of an anionic dispersant, a non-ionic dispersant and a polymeric dispersant;', 'a2) 30-70 wt % of ethylene glycol, based on the total weight of the thermal insulation slurry; and'} b1) 5-25 wt % of carbon black ...

Подробнее
13-01-2022 дата публикации

Polymeric Sheet Useful for Application to Concave Surface Topographies of Articles and Related Methods

Номер: US20220010083A1
Принадлежит: ENTROTECH, INC.

Polymeric sheets of the invention comprise sequential layers as follows: a topcoat layer, a polyurethane-based carrier layer, and an adhesive layer. The polyurethane-based carrier layer is formed using essentially no chain extender having a molecular weight of 350 grams/mole or less, resulting in a relatively low storage modulus polymeric sheet. Such polymeric sheets are particularly useful for application to surfaces having a concave topography. 1. A polymeric sheet comprising sequential layers as follows:a topcoat layer;a polyurethane-based carrier layer, wherein essentially no chain extender having a molecular weight of 350 grams/mole or less is used in formation of the polyurethane-based carrier layer; andan adhesive layer.2. The polymeric sheet of claim 1 , wherein the adhesive layer comprises a pressure-sensitive adhesive.3. The polymeric sheet of claim 1 , further comprising a release film on an exterior surface of the adhesive layer.4. The polymeric sheet of claim 1 , further comprising a carrier film on an exterior surface of the topcoat layer.5. The polymeric sheet of claim 1 , wherein the carrier layer is in-situ polymerized.6. The polymeric sheet of claim 1 , wherein essentially no butane diol is used in formation of the polyurethane-based carrier layer.7. The polymeric sheet of claim 1 , wherein essentially no polyols having a molecular weight of 1 claim 1 ,000 grams/mole or greater are used in formation of the polyurethane-based carrier layer.8. The polymeric sheet of claim 1 , wherein each polyol used in formation of the polyurethane-based carrier layer has a molecular weight between about 350 grams/mole and about 1 claim 1 ,000 grams/mole.9. The polymeric sheet of claim 1 , wherein each polyol used in formation of the polyurethane-based carrier layer has a molecular weight between about 350 grams/mole and about 450 grams/mole.10. The polymeric sheet of claim 1 , wherein the only polyol used in formation of the polyurethane-based carrier layer is a ...

Подробнее
04-01-2018 дата публикации

FILM OR SHEET, AND SCREEN

Номер: US20180004078A1
Принадлежит: Asahi Glass Company, Limited

To provide a film or sheet and a screen excellent in visibility of a projected image, in see-through properties when an image is not projected and in bending resistance. A single-layer film or sheet comprising a fluororesin, a light-scattering agent and a light absorbing agent, characterized in that the light-scattering agent is at least one light-scattering agent selected from the group consisting of a titanium oxide-containing pigment, a zinc oxide-containing pigment and a cerium oxide-containing pigment, and the content thereof is from 0.01 to 0.175 g/m, and the light absorbing agent is at least one light absorbing agent selected from the group consisting of carbon black, a black interference aluminum pigment, black iron oxide and titanium black, and the content thereof is from 0.0005 to 0.035 g/m. 1. A film or sheet which is a single layer film or sheet comprising a fluororesin , a light scattering agent and a light absorbing agent , and which is characterized in that{'sup': '2', 'the light-scattering agent is at least one light-scattering agent selected from the group consisting of a titanium oxide-containing pigment, a zinc oxide-containing pigment and a cerium oxide-containing pigment, and the content thereof is from 0.01 to 0.175 g/m, and'}{'sup': '2', 'the light absorbing agent is at least one light absorbing agent selected from the group consisting of carbon black, a black interference aluminum pigment, black iron oxide and titanium black, and the content thereof is from 0.0005 to 0.035 g/m.'}2. The film or sheet according to claim 1 , wherein the titanium oxide-containing pigment is a composite having part or all of the surface of titanium oxide particles coated with at least one of coating materials selected from the group consisting of silicon oxide claim 1 , aluminum oxide claim 1 , talc claim 1 , zirconium oxide claim 1 , calcium carbonate claim 1 , barium sulfate claim 1 , aluminum hydroxide claim 1 , magnesium hydroxide claim 1 , boehmite claim 1 , ...

Подробнее
07-01-2021 дата публикации

CONDUCTIVE FILM, METHOD FOR PRODUCING SAME, CONDUCTOR, RESIST PATTERN FORMATION METHOD, AND LAMINATE

Номер: US20210005343A1
Принадлежит: MITSUBISHI CHEMICAL CORPORATION

The conductive film of the present invention includes a conductive polymer (A) and has a film thickness of 35 nm or less, wherein: a surface resistance of the conductive film is 1×10Ω/sq. or less, and a standard deviation of current that flows through the conductive film upon application of voltage to the conductive film is 5 or less. The conductor of the present invention has a substrate, and the conductive film provided on at least a part of the surface of the substrate. The resist pattern forming method of the present invention includes a lamination step of forming the conductive film on a surface of a resist layer including a chemically amplified resist, said resist layer formed on one surface of a substrate, and an exposure step of irradiating the substrate with an electron beam according to a pattern on its side on which the conductive film is formed. The laminate of the present invention has a resist layer and an antistatic film formed on the surface of the resist layer, wherein the antistatic film is the above-mentioned conductive film. 1. A conductive film comprising a conductive polymer (A) and having a film thickness of 35 nm or less , wherein:{'sup': '11', 'a surface resistivity of the conductive film is 1×10Ω/sq. or less, and'}a standard deviation of current that flows through the conductive film upon application of voltage to the conductive film is 5 or less.2. The conductive film according to claim 1 , which further comprises a basic compound (B).3. The conductive film according to claim 1 , which further comprises a surfactant.4. The conductive film according to claim 2 , which further comprises a surfactant.5. The conductive film according to claim 1 , wherein the conductive polymer (A) has an acidic group.6. The conductive film according to claim 2 , wherein the conductive polymer (A) has an acidic group.7. The conductive film according to claim 3 , wherein the conductive polymer (A) has an acidic group.11. The conductive film according to claim 1 ...

Подробнее
02-01-2020 дата публикации

METHOD FOR MANUFACTURING ELECTRONIC COMPONENT, RESIN COMPOSITION FOR TEMPORARY PROTECTION, AND RESIN FILM FOR TEMPORARY PROTECTION

Номер: US20200006087A1
Принадлежит:

The present invention relates to a method for manufacturing an electronic component having an electromagnetic shield, comprising: a bonding step of bonding a temporary protective material on a workpiece with unevenness on the surface thereof; a photocuring step of curing the temporary protective material by light irradiation; a icing step of singulating the workpiece and the temporary protective material; a shielding step of forming a metal film on the portion of the singulated workpiece, the portion having no temporary protective material bonded thereon; and a peeling step of peeling the temporary protective material from the workpiece having the metal film formed, wherein the temporary protective material is formed from a resin composition for temporary protection with an elastic modulus at 25° C. of 3 MPa or less and an elastic modulus at 25° C. of 40 MPa or more after light irradiation with an exposure dose of 500 mJ/cmor more. 1. A method for manufacturing an electronic component having an electromagnetic shield , the method comprising:a bonding step of bonding a temporary protective material on a workpiece with unevenness on the surface thereof;a photocuring step of curing the temporary protective material by light irradiation;a dicing step of singulating the workpiece and the temporary protective material;a shielding step of forming a metal film on a portion of the singulated workpiece, the portion having no temporary protective material bonded thereon; anda peeling step of peeling the temporary protective material from the workpiece having the metal film formed,{'sup': '2', 'wherein the temporary protective material is formed from a resin composition for temporary protection with an elastic modulus at 25° C. of 3 MPa or less and an elastic modulus at 25° C. of 40 MPa or more after light irradiation with an exposure dose of 500 mJ/cmor more.'}2. The method according to claim 1 , wherein the resin composition has a tack force of 1 to 5 N as measured at 25° C. ...

Подробнее
20-01-2022 дата публикации

NOVEL PROCESS FOR THE PURIFICATION OF SUGAMMADEX SODIUM

Номер: US20220017650A1
Принадлежит:

The present invention relates to an improved process for the preparation of Sugammadex sodium (1). It further relates to a novel process for the purification of Sugammadex sodium (1) having impurity A less than 2% (w/w) and impurity E less than 0.1% (w/w) 2. The process as claimed in claim 1 , wherein the suitable halogenating agent is selected from the group comprising of methane sulfonyl chloride claim 1 , methane sulfonyl bromide claim 1 , oxalyl chloride and oxalyl bromide.3. The process as claimed in claim 1 , wherein the salts and esters of mercaptopropionic acid (2) is selected from a group comprising of sodium_mercaptopropionic acid claim 1 , potassium mercaptopropionic acid claim 1 , methyl-3-mercaptopropionate claim 1 , ethyl-3-mercaptopropionate claim 1 , isopropyl-3-mercaptopropionate.4. The process as claimed in claim 1 , wherein the suitable base is selected from a group comprising of sodium hydride claim 1 , potassium hydride claim 1 , sodium methoxide claim 1 , sodium ethoxide claim 1 , potassium methoxide claim 1 , sodium tertiary butoxide claim 1 , potassium tertiary butoxide; sodium carbonate claim 1 , potassium carbonate and cesium carbonates.5. A compound of Sugammadex sodium (1) having purity greater than 98.0% by HPLC and one or more of the following:i. impurity A less than 2.0% (w/w); andii. impurity E less than 0.1% (w/w)7. The process as claimed in and claim 1 , wherein the suitable solvent used herein is selected from water and suitable water miscible acid selected from the group comprising of hydrochloric acid claim 1 , sulfuric acid claim 1 , formic acid claim 1 , acetic acid claim 1 , propionic acid or mixture thereof.8. The process as claimed in and claim 1 , wherein the suitable biphasic solvent system is selected from group comprising mixture of water and organic solvent. water immiscible solvent is selected from a group comprising of hexane claim 1 , heptane claim 1 , cyclohexane claim 1 , toluene claim 1 , methyl acetate claim 1 , ...

Подробнее
20-01-2022 дата публикации

POLYIMIDE FILM COMPRISING AT LEAST TWO FILLERS HAVING DIFFERENT DIAMETERS, AND ELECTRONIC DEVICE COMPRISING SAME

Номер: US20220017711A1
Принадлежит: PI Advanced Materials Co., Ltd.

The present invention provides a polyimide film comprising an inorganic filler, which comprises a first filler group having a diameter (D50) of 2-2.7 μm and a second filler group having an average diameter (D50) of 1-1.7 μm, wherein the polyimide film satisfies relation 1: 0.7≤(D90−D10)/(D50)≤1.2, which is about the respective diameters of the first filler group and the second filler group. 1. A polyimide film , comprising a base film made of polyimide , and inorganic fillers dispersed in the base film ,wherein the polyimide film has a modulus of 3.5 GPa or less,the inorganic fillers include a first filler group having an average particle diameter (D50) falling within the range of 2 μm to 2.7 μm and a second filler group having an average particle diameter (D50) falling within the range of 1 μm to 1.7 μm, and {'br': None, 'i': D', 'D', 'D, '0.7≤(90−10)/50≤1.2\u2003\u2003(1).'}, 'each of the first filler group and the second filler group satisfies the following relational expression 1 for particle diameters2. The polyimide film of claim 1 , wherein the first filler group is included in an amount of 60% to 80% by weight and the second filler group is included in an amount of 20% to 40% by weight claim 1 , based on the total weight of the inorganic fillers.3. The polyimide film of claim 1 , wherein the inorganic fillers further include a third filler group having an average particle diameter (D50) falling within the range of 0.3 μm to 0.6 μm and satisfying the relational expression 1.4. The polyimide film of claim 3 , wherein the third filler group is included in an amount of 5% by weight or more to less than 20% by weight claim 3 , based on the total weight of the inorganic fillers.5. The polyimide film of claim 1 , wherein the inorganic filler is one or more selected from the group consisting of silica claim 1 , calcium phosphate claim 1 , calcium carbonate claim 1 , and barium sulfate.6. The polyimide film of claim 5 , wherein the inorganic filler is spherical ...

Подробнее
11-01-2018 дата публикации

Cyclodextrin Compositions Encapsulating a Selective ATP Inhibitor and Uses Thereof

Номер: US20180008541A1
Принадлежит:

The invention provides compositions comprising cyclodextrins encapsulating a selective ATP inhibitor, as well as uses thereof. 230-. (canceled) This application claims the benefit of U.S. Provisional Application No. 61/927,259, filed on Jan. 14, 2014, and U.S. Provisional Application No. 61/992,572, filed on May 13, 2014; which are hereby incorporated by reference.This invention was made with government support under Grant Numbers R01 CA160771, P30 CA006973, and NCRR UL1 RR 025005 awarded by the National Institutes of Health. The U.S. government has certain rights in the invention. This statement is included solely to comply with 37 C.F.R. §401.14(a)(f)(4) and should not be taken as an assertion or admission that the application discloses and/or claims only one invention.The knowledge that cancer cells rely on increased glycolysis rather than oxidative phosphorylation for survival is known as the “Warburg hypothesis” (Warburg (1956) 123:309-314). This concept constitutes the basis for using glycolysis and its associated enzymes as unique targets for the development of new anticancer therapeutic agents (Shaw (2006) 18:598-608; Gatenby and Gillies (2007) 39:1358-1366). One such agent is 3-bromopyruvate (3-BrPA), a synthetic brominated derivative of pyruvic acid that acts as an irreversible glycolytic inhibitor (Ko et al. (2001) 173:83-91; Geschwind et al. (2002) 62:3909-3913). It disrupts energy metabolism by targeting the glycolytic enzyme, glyceradehyde-3 phosphate dehydrogenase (GAPDH) (Ganapathy-Kanniappan et al. (2009) 29:4909-4918). Further, the anticancer effects of 3-BrPA have been consistent and reproducible against multiple tumor models both in vitro and in vivo. A wide variety of tumors have been demonstrated to be sensitive to 3-BrPA treatment, including, for example, liver cancer (Geschwind et al. (2002) 62:3909-30913; Vali et al. (2007) 18:95-101; and Ganapathy-Kanniappan et al. (2012) 262:834-845), pancreatic cancer (Cao et al. (2008) 14:1831-1839; ...

Подробнее
14-01-2021 дата публикации

Pharmaceutical compositions comprising meloxicam

Номер: US20210008211A1
Автор: Herriot Tabuteau

Disclosed herein are compositions comprising an NSAID such as meloxicam and/or rizatriptan in combination with a cyclodextrin and/or a carbonate or a bicarbonate. These compositions may be orally administered, for example, to improve the bioavailability or pharmacokinetics of the NSAID for the treatment of pain such as migraine, arthritis, and other conditions. Also disclosed herein are methods of treating pain, such as migraine, comprising administering meloxicam and rizatriptan to a human being suffering from pain, such as migraine. For migraine, these methods may be particularly useful when the meloxicam and rizatriptan are administered while the human being is suffering from an acute attack of migraine pain or migraine aura. In some embodiments, the combination of meloxicam and rizatriptan may be administered in a manner that results in a Tmax of meloxicam of 3 hours or less.

Подробнее
14-01-2016 дата публикации

MANUFACTURING PROCESS FOR CYCLODEXTRIN DERIVATIVES

Номер: US20160009826A1
Принадлежит:

A process and equipment assembly for reacting a substituent precursor with a cyclodextrin starting material to provide a raw product comprising a cyclodextrin derivative and 1% or less of an initial amount of the substituent precursor is provided, The process of the present invention provides cyclodextrin derivatives in substantially shorter time and with fewer side products than previous processes that utilize substantially the same starting materials. 1. A process for preparing a derivatized cyclodextrin , the process comprising: reacting a cyclodextrin starting material , a substituent precursor , and an optional catalyst to provide a raw product comprising a derivatized cyclodextrin , wherein the raw product comprises 1% or less of an initial amount of the substituent precursor.2. The process of claim 1 , wherein the process does not include after the reacting claim 1 , adding a reagent to the raw product in order to degrade the substituent precursor.3. The process of claim 1 , wherein the cyclodextrin starting material comprises an unsubstituted cyclodextrin selected from the group consisting of: an α-cyclodextrin claim 1 , a β cyclodextrin claim 1 , a γ cyclodextrin claim 1 , and combinations thereof.4. The process of claim 1 , wherein the substituent precursor and the cyclodextrin starting material are present in a molar ratio of 1:1 to 50:1.5. The process of claim 1 , wherein the substituent precursor is selected from the group consisting of: a sulfoalkylating agent claim 1 , an alkylating agent claim 1 , and combinations thereof.6. The process of claim 5 , wherein the substituent precursor is selected from the group consisting of: butane sultone claim 5 , diethyl sulfate claim 5 , and combinations thereof.7. The process of claim 1 , wherein the substituent precursor comprises a mixture of two or more substituent precursors.8. The process of claim 1 , wherein the optional catalyst is present in molar excess relative to the substituent precursor.9. The ...

Подробнее
14-01-2016 дата публикации

An Improved Process for Preparation of Sugammadex Sodium

Номер: US20160009827A1
Принадлежит:

The present invention provides a process for the preparation of sugammadex sodium involving the step of: reacting 6-perdeoxy-6-per-halo-gamma-cyclodextrin with 3-mercapto propionic acid in the presence of alkali metal alkoxide in an organic solvents. The invention also provides a process for purifying the sugammadex or its pharmaceutically acceptable salts using water and organic solvents. 2. The process as claimed in claim 1 , wherein said phosphorous halide is selected from the reagents PXand PX.3. The process as claimed in claim 1 , wherein said organic solvent in step (i) is selected from polar organic solvents.4. The process as claimed in claim 1 , wherein said alkali metal alkoxide is selected from the group comprising of sodium methoxide claim 1 , potassium methoxide claim 1 , sodium tertiary butoxide and potassium tertiary butoxide claim 1 , or mixtures thereof.5. The process as claimed in claim 1 , wherein said organic solvent in step (ii) is selected from the group comprising of polar aprotic solvents claim 1 , alcohol solvents claim 1 , hydrocarbon solvents claim 1 , ether solvents and mixtures thereof.6. A process for preparing Sugammadex sodium comprising the step of reacting 6-perdeoxy-6-per-halo-gamma-cyclodextrin with 3-mercapto propionic acid in presence of alkali metal alkoxide in an organic solvent claim 1 , wherein the halogen is fluorine claim 1 , chlorine claim 1 , bromide or iodine.7. The process as claimed in claim 6 , wherein said alkali metal alkoxide is selected from the group comprising of sodium methoxide claim 6 , potassium methoxide claim 6 , sodium tertiary butoxide claim 6 , potassium tertiary butoxide claim 6 , or mixtures thereof.8. The process as claimed in claim 6 , wherein said organic solvent is selected from the group comprising of polar aprotic solvents claim 6 , alcohol solvents claim 6 , hydrocarbon solvents claim 6 , ether solvents and mixtures thereof.9. A process for purification of the Sugammadex or its salts comprising ...

Подробнее
09-01-2020 дата публикации

PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM

Номер: US20200009250A1
Автор: Tabuteau Herriot
Принадлежит:

Disclosed herein are compositions comprising an NSAID such as meloxicam and/or rizatriptan in combination with a cyclodextrin and/or a carbonate or a bicarbonate. These compositions may be orally administered, for example, to improve the bioavailability or pharmacokinetics of the NSAID for the treatment of pain such as migraine, arthritis, and other conditions. Also disclosed herein are methods of treating pain, such as migraine, comprising administering meloxicam and rizatriptan to a human being suffering from pain, such as migraine. For migraine, these methods may be particularly useful when the meloxicam and rizatriptan are administered while the human being is suffering from an acute attack of migraine pain or migraine aura. In some embodiments, the combination of meloxicam and rizatriptan may be administered in a manner that results in a Tof meloxicam of 3 hours or less. 1. A method of treating migraine comprising: selecting a human migraine patient with a history of inadequate response to prior migraine treatments , and orally administering a dosage form to the migraine patient , wherein the dosage form comprises a combination of: 1) a complex of meloxicam with a sulfobutyl ether β-cyclodextrin (SBEβCD) , 2) a bicarbonate , and 3) a rizatriptan , wherein the human migraine patient is free of phonophobia two hours after the dosage form is orally administered to the human migraine patient.2. The method of claim 1 , wherein the dosage form contains 400 mg to 600 mg of the bicarbonate.3. The method of claim 1 , wherein the dosage form contains about 5 mg to about 50 mg of meloxicam.4. The method of claim 1 , wherein the dosage form contains about 50 mg to about 200 mg of the SBEβCD.5. The method of claim 1 , wherein the dosage form is a solid oral dosage form having a shorter Tof meloxicam in the human being than a reference dosage form that: 1) contains the same amount of meloxicam claim 1 , 2) does not contain an SBEβCD claim 1 , and 3) does not contain a ...

Подробнее
08-01-2015 дата публикации

Hydrogel compositions

Номер: US20150011504A1
Принадлежит:

Fragmented polysaccharide based hydrogel compositions and methods of making and using the same are provided. The subject polysaccharide based hydrogel compositions are prepared by combining a polysaccharide component with a hydrophilic polymer and a cross-linking agent. Also provided are kits and systems for use in preparing the subject compositions. 142-. (canceled)43. A hydrogel composition , comprisinga polysaccharide or derivative thereof having a molecular weight of 160 Dalton to 80,300 Dalton, a degree of deacetylation of 70% to 99%, and at least two nucleophilic groups, wherein the polysaccharide or derivative thereof is soluble in an aqueous solution;a multifunctional, multi-armed polyethylene glycol polymer of a molecular weight of 5,000 Dalton to 30,000 Dalton, and comprising at least two nucleophilic groups; anda multifunctional, multi-armed crosslinker of polyethylene glycol having a molecular weight of 5,000 Dalton to 30,000 Dalton, and comprising at least two electrophilic groups,wherein each one of the polysaccharide or derivative thereof, polyethylene glycol polymer and multi-armed crosslinker are crosslinked to each other.44. The composition of claim 43 , wherein the aqueous solution is alkaline and the polysaccharide is soluble in the aqueous solution up to a concentration of 30 mM.45. A hydrogel composition claim 43 , comprisinga chitosan or derivative thereof having a molecular weight of less than or equal to 5,000 Dalton, a degree of deacetylation of 70% to 99%, and at least two nucleophilic groups, wherein the chitosan or derivative thereof is soluble in an aqueous solution;a multifunctional, multi-armed polyethylene glycol polymer of a molecular weight of 5,000 Dalton to 30,000 Dalton, and comprising at least two nucleophilic groups; anda multifunctional, multi-armed crosslinker of polyethylene glycol having a molecular weight of 5,000 Dalton to 30,000 Dalton, and comprising at least two electrophilic groups;wherein the polyethylene glycol ...

Подробнее
14-01-2021 дата публикации

POLY(VINYL ALCOHOL) FILM AND PRODUCTION METHOD FOR POLARIZING FILM

Номер: US20210009772A1
Принадлежит: Sekisui Chemical Co., Ltd.

A polyvinyl alcohol film comprises a vinyl alcohol-based polymer, wherein, when the polyvinyl alcohol film being measured by a solid echo method using pulse NMR at 60° C. for waveform separation of a free induction decay curve of 1H spin-spin relaxation into three curves derived from three components a component A, a component B, and a component C in order of short relaxation time, the component A has a resulting relaxation time of 0.0070 milliseconds or more and 0.0092 milliseconds or less, and a resulting component ratio of 20% or more and 50% or less. 1. A polyvinyl alcohol film comprising a vinyl alcohol-based polymer ,wherein, when the polyvinyl alcohol film is measured by a solid echo method using pulse NMR at 60° C. for waveform separation of a free induction decay curve of 1H spin-spin relaxation into three curves derived from three components a component A, a component B, and a component C in order of short relaxation time, the component A has a resulting relaxation time of 0.0070 milliseconds or more and 0.0092 milliseconds or less, and a resulting component ratio of 20% or more and 50% or less.2. The polyvinyl alcohol film according to claim 1 , wherein the vinyl alcohol-based polymer has a degree of saponification of 99 mol % or more.3. The polyvinyl alcohol film according to claim 1 , wherein the vinyl alcohol-based polymer has a degree of polymerization of 2000 or more and 4000 or less.4. The polyvinyl alcohol film according to claim 1 , comprising a plasticizer.5. The polyvinyl alcohol film according to claim 1 , for use in a polarizing film.6. A method for manufacturing a polarizing film comprising using the polyvinyl alcohol film according to .7. The method for manufacturing a polarizing film according to claim 6 , comprising steps of dyeing the polyvinyl alcohol film claim 6 , stretching the polyvinyl alcohol film claim 6 , and performing a fixation treatment to the dyed polyvinyl alcohol film.8. The method for manufacturing a polarizing film ...

Подробнее
14-01-2021 дата публикации

METHODS FOR ENHANCING THE BONDING STRENGTH OF THERMOSET ADHESIVES AND SEALANTS VIA DISULFIDE DYNAMIC CHEMISTRY

Номер: US20210009872A1
Принадлежит:

Curable compositions for dynamic epoxy-based thermoset adhesives and/or sealants are provided. Methods of applying the compositions to form strong, low-stress, cured adhesive polymer films are also provided. The cured polymer films use crosslinkers that include disulfide and carbon-nitrogen bonds, wherein the disulfide bonds impart dynamic chemistry to the polymer network structure in order to the achieve adaptable thermoset adhesives and sealants. 2. The composition of claim 1 , wherein the polymer is poly[(phenyl glycidyl ether)-co-formaldehyde].3. The composition of claim 1 , wherein the poly[(phenyl glycidyl ether)-co-formaldehyde] has a number average molecular weight of at least 320.4. The composition of claim 2 , wherein the poly[(phenyl glycidyl ether)-co-formaldehyde] has a number average molecular weight in the range from 320 to 6000.5. The composition of claim 1 , wherein the crosslinker has the structure HN—X—S—S—X—NH claim 1 , wherein X represents an aliphatic or aromatic hydrocarbon group having from one to ten carbon atoms.6. The composition of claim 5 , wherein the crosslinker is cystamine.7. The composition of claim 1 , wherein the at least two reactive amine groups are hydrazine groups.8. The composition of claim 1 , wherein the crosslinker is cystamine.9. The composition of claim 1 , wherein the mole ratio of amine groups on the crosslinker to epoxy groups on the polymer is at least 1:2.11. The polymer film of claim 10 , wherein the polymer is poly[(phenyl glycidyl ether)-co-formaldehyde].12. The polymer film of claim 11 , wherein the poly[(phenyl glycidyl ether)-co-formaldehyde] has a number average molecular weight in the range from 320 to 6000.13. The polymer film of claim 10 , wherein the crosslinker has the structure HN—X—S—S—X—NH claim 10 , wherein X represents an aliphatic or aromatic hydrocarbon group having from one to ten carbon atoms.14. The polymer film of claim 10 , wherein the crosslinker is cystamine.15. The composition of claim 12 ...

Подробнее
10-01-2019 дата публикации

6-Deoxy-6-Thioether-Amino Acid Cyclodextrin Derivative and Preparation Method Thereof

Номер: US20190010255A1
Автор: Qi Youmao
Принадлежит:

6-deoxy-6-thioether-amino acid cyclodextrin derivative is obtained by condensing an amino acid derivative with halogenated cyclodextrin in presence of alkali. The 6-deoxy-6-thioether-amino acid cyclodextrin derivative includes 6-deoxysulfinyl-6-thioether-amino acid cyclodextrin derivative and 6-deoxysulfonyl-6-thioether-amino acid cyclodextrin derivative. Compounds provided are for reversing neuromuscular relaxation in patients and animals induced by muscular relaxants. The compounds are able to rapidly reverse and antagonize muscular relaxation induced by muscular relaxants and can be administrated in preparing a drug having an antagonist effect on muscular relaxation. The compounds have low production cost and are able to reverse and antagonize a wide rage of muscular relaxations, thus effectively broaden scope of clinical use. More importantly, the compounds have a safe dose at least doubled compared to prior arts. The compounds have a general formula (I). 14-. (canceled)6. The method of claim 5 , wherein M is Na. This is a U.S. National Stage under 35 U.S.C. 371 of the International Application PCT/CN2011/082577, filed Nov. 21, 2011, which claims priority under 35 U.S.C. 119(a-d) to CN 201010566606.3, filed Nov. 26, 2010.The present invention relates to a chemical pharmaceutical field, and more particularly to a 6-deoxy-6-thioether-amino acid cyclodextrin derivative and a preparation method thereof, mainly comprising a 6-deoxysulfinyl-6-thioether-amino acid cyclodextrin derivative, a 6-deoxysulfonyl-6-thioether-amino acid cyclodextrin derivative, preparation methods thereof, and a method for antagonizing muscular relaxation comprising administrating a drug comprising a therapeutically effective amount of the 6-deoxy-6-thioether-amino acid cyclodextrin derivative, wherein the drug is able to rapidly reverse the muscular relaxation induced by muscular relaxant and have features of high pharmaceutical security, available reactants and low cost.In 1986, it was ...

Подробнее
09-01-2020 дата публикации

CAPPED CYCLODEXTRIN-HYDROPHOBIC MOIETY CONJUGATE, CYCLODEXTRIN SUPRAMOLECULAR POLYMER, AND CYCLODEXTRIN-siRNA COMPLEX AND METHOD OF SYNTHESIS THEREOF

Номер: US20200010576A1
Принадлежит:

The invention relates to a capped cyclodextrin-hydrophobic moiety conjugate, to a supramolecular polymer formed of capped cyclodextrin-hydrophobic moiety conjugates according to the invention and to a siRNA-cyclodextrin complex comprising a supramolecular polymer according to the invention. The invention also relates to a method for manufacturing the capped cyclodextrin-hydrophobic moiety conjugate, the supramolecular polymer, the siRNA-cyclodextrin complex according to the invention. The capped cyclodextrin-hydrophobic moiety conjugate of the invention comprises a capped cyclodextrin group and at least one hydrophobic moiety bound by a first linker to one of the carbon atoms of the cap. The invention can be used for various applications in particular in the pharmaceutical field. 1. A capped cyclodextrin-hydrophobic moiety conjugate comprising a cyclodextrin group and at least one hydrophobic moiety , wherein:the cyclodextrin group is capped on its primary rim by a cap binding a first carbon atom, previously bearing a hydroxyl group, of a first glucopyranose unit to a second carbon, previously bearing an hydroxyl group, of a second and different glucopyranose unit, said first and second glucopyranose units being preferably separated from each other by at least one, andthe hydrophobic moiety is bound by a first linker to one of the carbon atoms of the cap, and{'sub': 2', '13', '5', '6', '3', '8, 'the hydrophobic moiety is chosen among an adamantane group, a C-Calkyl group optionally containing at least one heteroatom, a C-Caromatic group optionally containing at least one heteroatom and a C-Cnon-aromatic cycle optionally containing at least one heteroatom.'}2. The capped cyclodextrin-hydrophobic moiety conjugate according to claim 1 , wherein the hydrophobic moiety is chosen among an adamantane group and a phenyl group claim 1 , preferably the hydrophobic moiety is an adamantane group.3. The capped cyclodextrin-hydrophobic moiety conjugate of claim 1 , wherein:said ...

Подробнее
09-01-2020 дата публикации

POROUS FILM SEALING METHOD AND POROUS FILM SEALING MATERIAL

Номер: US20200010630A1
Принадлежит:

A porous film sealing method and porous film sealing material are provided to seal an object to be sealed that has a porous film. 1. A method to seal a hole within a porous film comprising the step ofsupplying a first material to a treatment vessel, the treatment vessel containing an object having the porous film, whereinthe first material comprises a non-aromatic fluorocarbon having 6 or more carbon atoms.2. The porous film sealing method as claimed in wherein claim 1 ,in the first step,the first material is introduced into the treatment vessel in a gas state, and whereinthe first material seals the holes within the porous film.3. The porous film sealing method as claimed in wherein claim 1 ,in the first step,the first material is introduced into the treatment vessel in a liquid state, and whereinthe first material seals the holes within the porous film.4. The porous film sealing method as claimed in further comprising a second step of forming a plasma from the first material.5. The porous film sealing method as claimed inwhereinthe plasma of the first material acts as an etching gas in the second step.6. The porous film sealing method as claimed in further comprising a third step of removing the first material from the holes in the porous film by increasing a temperature within the treatment vessel and/or decreasing a pressure within the treatment vessel.7. The porous film sealing method as claimed in claim 1 , wherein the first material has a ring structure claim 1 , and a vapor pressure of the first material at a temperature of 25° C. is from 0.05 Torr to 25 Torr.8. The porous film sealing method as claimed in claim 1 , wherein the first material has a straight chain or a branched structure claim 1 , and a vapor pressure of the first material at a temperature of 25° C. is from 0.05 Torr to 40 Torr.9. The porous film sealing method as claimed in claim 1 , wherein a vapor pressure range of the first material in a temperature range from −50° C. to −20° C. is from 0 ...

Подробнее
03-02-2022 дата публикации

COATING COMPOSITIONS AND METHODS OF USE THEREOF

Номер: US20220030895A1
Принадлежит: PolyNatural Holding SPA

Aspects of the disclosure provide coating compositions and methods of use thereof. 143-. (canceled)44. A coating composition , comprising the following components:(a) a polysaccharide;(b) one or more constituents of a vegetable, wherein the one or more constituents of a vegetable comprises a soybean oil; and(c) at least one surfactant, wherein the at least one surfactant is a saponin or a phospholipid of sunflower or soybean,wherein the coating composition is an emulsified mixture of the components formulated for coating an outer surface of a post-harvest fruit, and wherein the components are present in the composition in amounts effective for preserving the post-harvest fruit.45. The composition of claim 44 , wherein the surfactant is derived from a natural extract or plant extract.46. The composition of claim 44 , wherein the polysaccharide is a seaweed polysaccharide.47. The composition of claim 44 , wherein the polysaccharide is derived from wood pulp claim 44 , plants claim 44 , or algae.48. The composition of claim 44 , wherein the polysaccharide is extracted from plants or algae.49. The composition of claim 44 , wherein the polysaccharide comprises a beta-1 claim 44 ,4 (β-1 claim 44 ,4) linked glucose polysaccharide.50. The composition of claim 44 , wherein the composition further comprises:(d) a beeswax or a carnauba wax.51. The composition of claim 44 , wherein the nanocellulose polysaccharide is extracted from a red edible seaweed.52. The composition of claim 44 , wherein the composition further comprises an active ingredient.53. The composition of claim 52 , wherein the active ingredient comprises an antimicrobial claim 52 , citric acid claim 52 , sodium citrate claim 52 , sodium benzoate claim 52 , and/or potassium sorbate.54. The composition of claim 44 , wherein:(a) the polysaccharide is present at a concentration of between about 0.01% and about 3% weight-to-volume (w/v);(b) the one or more constituents of a vegetable is present at a concentration of ...

Подробнее
15-01-2015 дата публикации

SILANE-CONTAINING ETHYLENE INTERPOLYMER FORMULATION INCLUDING FILMS AND ELECTRONIC DEVICE MODULE COMPRISING SAME

Номер: US20150013753A1
Принадлежит:

Disclosed in more detail in this application are ethylene interpolymer films having one or more layers, comprising surface layer comprising: (A) a silane-containing ethylene interpolymer comprising (1) an ethylene interpolymer having a density of less than 0.905 g/cm3, and (2) at least 0.1 percent by weight alkoxysilane; characterized by: (3) having a volume resistivity of greater than 5×1015 ohm-cm as measured at 60 C. In one embodiment, such ethylene interpolymer has a residual boron content of less than 10 ppm and residual aluminum content of less than 100 ppm. Also disclosed are laminated electronic device modules comprising: A. at least one electronic device, and B. one of the ethylene interpolymer films as described above in intimate contact with at least one surface of the electronic device. Such laminated electronic device modules according to the invention have been shown to suffer reduced potential induced degradation (“PID”). 1. An ethylene interpolymer film having one or more layers , comprising surface layer comprising: (1) an ethylene interpolymer having a density of less than 0.905 g/cm3, and', '(2) at least 0.1 percent by weight alkoxysilane;, '(A) a silane-containing ethylene interpolymer comprising'} {'sup': '15', '(3) having a volume resistivity of greater than 5×10ohm-cm as measured at 60° C.'}, 'characterized by2. The ethylene interpolymer film according to wherein ethylene interpolymer has a residual boron content of less than 10 ppm and a residual aluminum content of less than 100 ppm claim 1 , both contents being based on weight of ethylene interpolymer.3. The ethylene interpolymer film according to wherein the ethylene interpolymer is prepared using a catalyst comprising a complex of bis-(biphenylphenol) ligands coordinated through oxygen atoms to a transition metal.4. The ethylene interpolymer film according to wherein the transition metal is selected from the group consisting of Ti claim 3 , Zr and Hf.5. The ethylene interpolymer film ...

Подробнее
15-01-2015 дата публикации

EVA SHEET COMPRISING MICROPARTICLES FOR SOLAR CELL AND METHOD FOR MANUFACTURING THE SAME

Номер: US20150013760A1
Принадлежит:

An EVA sheet for a photovoltaic module comprising microparticles, the main component of which is an ethylene-vinyl acetate resin is provided. 1. An EVA sheet for a photovoltaic module comprising microparticles , the main component of which is an ethylene-vinyl acetate resin.2. An EVA sheet for a photovoltaic module according to claim 1 , wherein the microparticles exist in a fused state with each other.3. An EVA sheet for a photovoltaic module according to claim 1 , wherein the microparticles further comprise 0.1 to 5 parts by weight of a crosslinking agent claim 1 , 0.1 to 3 parts by weight of a co-crosslinking agent claim 1 , and 0.1 to 3 parts by weight of a ultraviolet ray blocking agent to 100 parts by weight based on the ethylene-vinyl acetate resin.4. An EVA sheet for a photovoltaic module according to claim 1 , wherein a mean particle diameter of the microparticles is 200 to 400 μm.5. An EVA sheet for a photovoltaic module according to claim 1 , wherein an angle of repose of the microparticles is 40° or less.6. An EVA sheet for a photovoltaic module according to claim 1 , wherein a thickness of the EVA sheet is 250 to 400 μm.7. A method for manufacturing an EVA sheet for a photovoltaic module comprising the steps of:(a) preparing microparticles, the main component of which is an ethylene-vinyl acetate;(b) dispersing the microparticles; and(c) sintering the dispersed microparticles.8. A method for manufacturing an EVA sheet for a photovoltaic module according to claim 7 , in the step (a) claim 7 , the microparticles are manufactured by freeze pulverizing.9. A method for manufacturing an EVA sheet for a photovoltaic module according to claim 8 , wherein the freeze pulverizing is performed at temperatures of −150 to −100° C.10. A method for manufacturing an EVA sheet for a photovoltaic module according to claim 7 , in the step (b) claim 7 , the microparticles are dispersed in a thickness of 750 to 1 claim 7 ,200 μm. The present invention provides an EVA sheet ...

Подробнее
19-01-2017 дата публикации

ANTHOCYANIDIN COMPLEX

Номер: US20170014377A1
Принадлежит:

The invention relates to a complex of an anthocyanidin and a methylated β-cyclodextrin which can be formulated as an aqueous solution and as a solid, and to a process for the preparation of such a complex. Complexes according to the invention are storage-stable and can be readily formulated in aqueous solution. 1. A complex of an anthocyanidin and a methylated β-cyclodextrin.2. The complex as claimed in or , characterized in that the degree of substitution of the β-cyclodextrin with methyl groups is from 10 to 15 , preferably from 11 to 14 , more preferably from 12 to 13.3. The complex as claimed in claim 2 , characterized in that the methylated β-cyclodextrin is RAMEB.4. The complex as claimed in one of to claim 2 , characterized in that the anthocyanidins are selected from the group consisting of aurantinidin claim 2 , cyanidin claim 2 , delphinidin claim 2 , europinidin claim 2 , luteolinidin claim 2 , pelargonidin claim 2 , malvidin claim 2 , peonidin claim 2 , petunidin and rosinidin.5. The complex as claimed in claim 4 , characterized in that the anthocyanidin is delphinidin.6. An aqueous solution of a complex as claimed in one of to .7. The aqueous solution as claimed in claim 6 , characterized in that the concentration of the anthocyanidin claim 6 , calculated as chloride claim 6 , is at least 10 mg/ml claim 6 , more preferably at least 20 mg/ml claim 6 , more preferably at least 50 mg/ml claim 6 , more preferably at least 80 mg/ml.8. A solid comprising a complex of an anthocyanidin and a methylated β-cyclodextrin claim 6 , obtainable by removing the solvent from an aqueous solution as claimed in either of and .9. A process for the preparation of a complex of an anthocyanidin and a methylated β-cyclodextrin claim 6 , comprising the steps:a) preparing an aqueous solution of the methylated β-cyclodextrin,b) adding the anthocyanidin and mixing to prepare the complex.10. The process as claimed in claim 9 , characterized in that the solution prepared in step a) ...

Подробнее
21-01-2016 дата публикации

SOLVENT-CONTAINING DRY FILM AND METHOD FOR APPLYING THE SAME ON A SUBSTRATE

Номер: US20160017105A1
Принадлежит: ETERNAL MATERIALS CO., LTD.

The present disclosure relates to a solvent-containing dry film and a method for applying a dry film on a substrate. The dry film includes a carrier and a resin layer. The resin layer contains a resin composition and a solvent and the solvent is present in a total amount of at least 5 wt % based on the total weight of the resin layer. The dry film of the present invention can be applied onto a substrate without the use of a prior art vacuum lamination apparatus. The application process is simple and is more cost-efficient than the prior art techniques.

Подробнее
18-01-2018 дата публикации

SUGAMMADEX PREPARATION AND PURIFICATION METHOD

Номер: US20180016359A1
Принадлежит:

The present invention provides a process for the preparation of (6-per-deoxy-6-per-(2-carboxyethyl)thio-γ-cyclodextrin) sodium salt, comprising the steps of: 1. A process for the preparation of 6-per-deoxy-6-per-(2-carboxyethyl)thio-γ-cyclodextrin sodium salt , which comprises the steps of:reacting γ-cyclodextrin(SM1) with iodine in the presence of triphenylphosphine in an organic solvent to afford an intermediate, 6-per-deoxy-6-iodo-γ-cyclodextrin (SGMD-1);adding methanol solution of sodium methoxide into the reaction system followed by the addition of acetone without removal of the solvents under reduced pressure to obtain the crude product of SGMD-1 as a solid after filtration;purifying the crude SGMD-1 by recrystallization;reacting thus obtained recrystallized intermediate (SGMD-1) with 3-mercaptopropionic acid (SM2) in basic medium e.g., sodium hydride, to obtain a crude product of 6-per-deoxy-6-per-(2-carboxyethyl)thio-γ-cyclodextrinsodium salt (SGMD);purifying the crude SGMD by passing through adsorbents followed by recrystallization.2. The process according to claim 1 , characterized in that the organic solvent is N claim 1 ,N-dimethylformamide (DMF).3. The process according to claim 1 , characterized in that the ratio (V/W) of acetone and γ-cyclodextrin (SM1) is 30:1˜150:1 claim 1 , preferably 35:1˜140:1 claim 1 , 40:1˜130:1 claim 1 , 45:1˜120:1 claim 1 , 50:1˜110:1 claim 1 , 50:1˜100:1 claim 1 , and most preferably 60:1˜100:1.4. The process according to claim 1 , characterized in that the solvents used in the recrystallization of crude SGMD-1 are N claim 1 ,N-dimethylformamide claim 1 , dimethyl sulfoxide (DMSO) claim 1 , methanol claim 1 , ethanol claim 1 , isopropanol or acetone or the mixture of the two above solvents claim 1 , preferably a mixture of acetone and DMF claim 1 , a mixture of acetone and DMSO claim 1 , or a mixture of methanol and DMF or a mixture of ethanol and DMF claim 1 , and most preferably a mixture of acetone and DMF.5. The process ...

Подробнее
15-01-2015 дата публикации

POLYIMIDE FILM AND FABRICATION METHOD THEREOF

Номер: US20150018484A1
Принадлежит: Taimide Technology Incorporation

A polyimide film includes a polyimide polymer forming a main molecular structure of the polyimide film, and polyimide particles present in the polyimide film at a weight ratio between about 15 wt % and 30 wt % of a total weight of the polyimide film, the polyimide particles having an average diameter between about 3 μm and 8 μm. The polyimide film can have a 60° gloss value equal to or smaller than 10, a haze equal to or higher than 90%, and a Young's modulus equal to or higher than 280 kgf/mm. In some embodiments, methods of fabricating the polyimide film are also described. 1. A polyimide film comprising:a polyimide polymer forming a main molecular structure of the polyimide film; andpolyimide particles present in the polyimide film at a weight ratio between about 15 wt % and 30 wt % of a total weight of the polyimide film, the polyimide particles having an average diameter between about 3 μm and 8 μm.2. The polyimide film according to claim 1 , having a 60° gloss value equal to or smaller than 10.3. The polyimide film according to claim 1 , having a haze equal to or higher than 90%.4. The polyimide film according to claim 1 , having a Young's modulus equal to or higher than 280 kgf/mm.5. The polyimide film according to claim 1 , having a 60° gloss value equal to or smaller than 10 claim 1 , a haze equal to or higher than 90% claim 1 , and a Young's modulus equal to or higher than 280 kgf/mm.6. The polyimide film according to claim 1 , wherein the polyimide particles are obtained by reacting diamine monomers with dianhydride monomers claim 1 , the diamine monomers being selected from a group consisting of phenylenediamine (PDA) claim 1 , oxydianiline (ODA) and 2-(4-aminophenyl)-5-amino benzimidazole (PBOA) claim 1 , and the dianhydride monomers being selected from a group consisting of 3 claim 1 ,3′ claim 1 ,4 claim 1 ,4′-biphenyltetracarboxylic dianhydride (BPDA) and pyromellitic dianhydride (PMDA).7. The polyimide film according to claim 1 , wherein the ...

Подробнее
15-01-2015 дата публикации

HEAT-SHRINKABLE WHITE FILM

Номер: US20150018489A1
Принадлежит: C.I. Kasei Company, Limited

A heat-shrinkable white film including an amorphous polyethylene terephthalate; a cyclic olefin resin having a glass transition temperature of 100° C. or higher; and a polyester elastomer having a Vicat softening point of 150° C. or lower. 1an amorphous polyethylene terephthalate;a cyclic olefin resin having a glass transition temperature of 100° C. or higher;a polyester elastomer having a Vicat softening point of 150° C. or lower.. A heat-shrinkable white film comprising: The present invention relates to a heat-shrinkable white film.In general, a label formed of a heat-shrinkable film subjected to printing is mounted on a beverage or seasoning bottle.Most heat-shrinkable films which have been used in the past are transparent. However, white heat-shrinkable films are required from the viewpoint of diversification of designs. As a method of whitening a heat-shrinkable film, a method of containing an inorganic white pigment such as titanium oxide and a coating method using a white ink are proposed (for example, Patent Document 1 and 2).[Patent Document 1] Japanese Unexamined Patent Application, First Publication No. 2004-155482[Patent Document 2] Japanese Unexamined Patent Application, First Publication No. 2005-212226However, it is difficult to uniformly disperse an inorganic white pigment in a resin film. As a result, problems such as classification and an increase in specific gravity of the film occur. In addition, the coating method using a white ink is not easily performed.Moreover, when a label looks unattractive, a product having the label mounted thereon also gives a bad impression. Therefore, heat-shrinkable films are required to have high surface smoothness in order to improve the appearance of the label and to prevent print omission.An object of the invention is to provide a heat-shrinkable white film which has heat shrinkability, high concealability, and high surface smoothness, and is white and simple to obtain.The invention has the following aspect.A ...

Подробнее
17-01-2019 дата публикации

POLYAMIDE-IMIDE, METHOD FOR PREPARING SAME, AND POLYAMIDE-IMIDE FILM USING SAME

Номер: US20190016849A1
Принадлежит: LG CHEM, LTD.

The present invention provides a polyamide-imide, a method for preparing same, and a polyimide film using same. The polyamide-imide film exhibits excellent transparency, heat resistance, mechanical strength and flexibility, and thus may be used in various fields such as substrates for device, cover substrates for displays, optical films, integrated circuit (IC) packages, adhesive films, multi-layer flexible printed circuits (FPCs), tapes, touch panels and protective films for optical discs. 3. The polyamide-imide according to claim 1 , wherein the repeating structure of the Chemical Formula 1a and the repeating structure of the Chemical Formula 1b are polymerized at molar ratio of 1:5 to 2:1.4. The polyamide-imide according to claim 1 , wherein the repeating structure of the Chemical Formula 1a and the repeating structure of the Chemical Formula 1b are polymerized in the form of a random copolymer.8. The method for manufacturing the polyamide-imide according to claim 7 , wherein the tetracarboxylic dianhydride of the Chemical Formula 2 and the compound of the Chemical Formula 3 are added at molar ratio of 1:5 to 2:1.9. The method for manufacturing the polyamide-imide according to claim 7 , wherein the compounds of the Chemical Formula 2 and the Chemical Formula 3 and the diisocyanate of the Chemical Formula 4 are reacted at molar ratio of 1:1.1 to 1.1:1.10. The method for manufacturing the polyamide-imide according to claim 7 , wherein anhydride is further added in the step b) before reaction.11. A high strength transparent polyamide-imide film comprising the polyamide-imide according to .12. The high strength transparent polyamide-imide film according to claim 11 , which has haziness (Haze) of 2 or lower and yellowness index (YI) of 10 or lower.13. The high strength transparent polyamide-imide film according to claim 11 , which has pencil strength of 2H or higher.14. The polyamide-imide film according to claim 11 , which has coefficient of thermal expansion (CTE) ...

Подробнее
17-01-2019 дата публикации

DISPLAY APPARATUS

Номер: US20190016926A1
Принадлежит:

A display apparatus includes a display panel, a light guide unit disposed under the display panel that includes a light incident surface, an opposite surface opposite to the light incident surface, side surfaces connecting the light incident surface and the opposite surface, and a light exiting surface facing the display panel, and a foam tape attached on an edge of the light exiting surface and an edge of a lower surface of the display panel to fix the display panel and the light guide unit. The foam tape includes a first adhesive layer, a reflecting layer disposed on the first adhesive layer, a foam layer disposed on the reflecting layer, and a second adhesive layer disposed on the foam layer and attached to the display panel. 1. A display apparatus , comprising:a display panel;a light guide unit disposed under the display panel that includes a light incident surface, an opposite surface opposite to the light incident surface, side surfaces connecting the light incident surface and the opposite surface, and a light exiting surface facing the display panel; anda foam tape attached onto an edge of the light exiting surface and an edge of a lower surface of the display panel to fix the display panel and the light guide unit,wherein the foam tape comprises a first adhesive layer, a reflecting layer disposed on the first adhesive layer, a foam layer disposed on the reflecting layer, and a second adhesive layer disposed on the foam layer and attached to the display panel.2. The display apparatus of claim 1 , wherein the foam tape comprises a first foam tape claim 1 , a second foam tape claim 1 , and a third foam tape claim 1 ,the first foam tape is attached on an edge of the light exiting surface adjacent to the opposite surface,the second foam tape and the third foam tape are attached on edges of the light exiting surface adjacent to the side surfaces of the light guide unit, respectively.3. The display apparatus of claim 2 , wherein one or more of the first foam tape ...

Подробнее
16-01-2020 дата публикации

POLYETHYLENE COMPOSITION AND FILM HAVING A GOOD PERMEABILITY, STIFFNESS AND SEALABILITY

Номер: US20200017670A1
Принадлежит: NOVA CHEMICALS (INTERNATIONAL) S.A.

A polyethylene composition includes a first polyethylene which is an ethylene copolymer having a weight average molecular weight of from 70,000 to 250,000 and a molecular weight distribution M/Mof <2.3, a second polyethylene which is an ethylene copolymer or homopolymer having a weight average molecular weight of from 15,000 to 100,000 and a molecular weight distribution M/Mof <2.3, and a third polyethylene which is an ethylene copolymer or homopolymer having a weight average molecular weight of from 70,000 to 250,000 and a molecular weight distribution M/Mof >2.3, where the first polyethylene has more short chain branching than the second polyethylene or the third polyethylene. The polyethylene composition has a soluble fraction in a CEF analysis of at least 10 weight percent. Film made from the polyethylene composition may have a machine direction 1% secant modulus of ≥190 MPa (at a film thickness of about 1 mil), a seal initiation temperature (SIT) of ≤100° C. (at a film thickness of about 2 mil), an area of hot tack window (AHTW) of ≥160 Newtons·C° (at a film thickness of about 2 mil) and an oxygen transmission rate (OTR) of ≥650 cmper 100 inch(at a film thickness of about 1 mil). 1. A polyethylene composition comprising:{'sub': w', 'w', 'n, 'from 5 to 80 wt % of a first polyethylene which is an ethylene copolymer, the first polyethylene having a weight average molecular weight Mof from 70,000 to 250,000, a molecular weight distribution M/Mof <2.3 and from 5 to 100 short chain branches per thousand carbon atoms;'}{'sub': w', 'w', 'n, 'from 5 to 80 wt % of a second polyethylene which is an ethylene copolymer or an ethylene homopolymer, the second polyethylene having a weight average molecular weight Mof from 15,000 to 100,000, a molecular weight distribution M/Mof <2.3 and from 0 to 20 short chain branches per thousand carbon atoms; and'}{'sub': w', 'w', 'n, 'from 5 to 80 wt % of a third polyethylene which is an ethylene copolymer or an ethylene homopolymer, the ...

Подробнее
28-01-2016 дата публикации

ANTIFUNGAL COMPOSITE AND METHOD FOR MANUFACTURING THE SAME

Номер: US20160021876A1
Принадлежит:

The invention provides an antifungal composite comprising an antifungal agent and β-cyclodextrin surface-modified with a long carbon chain compound, wherein the antifungal agent is clad in β-cyclodextrin surface-modified with a long carbon chain compound as a carrier, and thus a use of inhibiting harmful fungi can be provided by sustained release of the antifungal agent from the composite. The antifungal composite may be retained on the surface of the resin materials to increase the concentration of the antifungal composite on the surface of the resin materials by adjusting the difference of the lipophilic and hydrophilic characters between the antifungal composite and the resin materials, and thus an antifungal effect can be increased. The invention also relates to a method for manufacturing an antifungal composite. 1. An antifungal composite comprising an antifungal agent and β-cyclodextrin , wherein the antifungal agent is clad in β-cyclodextrin , the weight ratio of β-cyclodextrin/the antifungal agent is from 1 to 10 , and the β-cyclodextrin is surface-modified with a long carbon chain compound.2. The antifungal composite as claimed in claim 1 , wherein the long carbon chain compound has 6-18 carbon atoms.3. The antifungal composite as claimed in claim 2 , wherein the long carbon chain compound is dodecyl trimethoxy silane claim 2 , octadecyl trimethoxysilane claim 2 , n-octyl triethoxy silane claim 2 , methyl trimethoxy silane claim 2 , methyl ethyl silane or sodium dodecyl benzene sulfonate.4. A method for manufacturing an antifungal composite comprising steps:solving β-cyclodextrin and an antifungal agent in a solvent by molar ratio of 1:1-10:1;mixing and carrying out a reaction of β-cyclodextrin and the antifungal agent for 1 hour to 2 hours to obtain a mixture; anddrying the mixture to obtain an antifungal composite with the antifungal agent clad in β-cyclodextrin.5. The method as claimed in claim 4 , wherein the β-cyclodextrin is surface-modified with a ...

Подробнее
25-01-2018 дата публикации

CUSHIONING MATERIAL HAVING SENSOR, AND BED

Номер: US20180020841A1
Принадлежит:

The cushioning material having a sensor includes a resin sheet composed of photoelastic resin, a cushioning material laminated on the resin sheet , a photosensor including a light generating unit and a light receiving unit that are disposed to face each other so as to sandwich the resin sheet , and a processor that detects a stress applied to the resin sheet based on the light signal detected by the photosensor 1. A cushioning material having a sensor , comprising:a resin sheet composed of photoelastic resin,a cushioning material laminated on the resin sheet,a photosensor including a light generating unit and a light receiving unit that receives light generated from the light generating unit through the resin sheet, anda processor that detects a stress applied to the resin sheet based on a light signal detected by the photosensor.2. The cushioning material having a sensor according to claim 1 , whereinthe light generating unit and the light receiving unit are disposed so as to overlap with the resin sheet on a plane of projection projected in a direction perpendicular to the thickness direction of the resin sheet.3. The cushioning material having a sensor according to claim 1 , whereinthe light generating unit is disposed so as to overlap with the resin sheet on a plane of projection projected in a direction perpendicular to the thickness direction of the resin sheet, andthe light receiving unit is disposed so as to overlap with the resin sheet on a plane of projection projected in the thickness direction of the resin sheet.4. The cushioning material having a sensor according to claim 3 , whereinthe cushioning material has a protruded accommodation unit for accommodating the light receiving unit.5. The cushioning material having a sensor according to claim 1 , wherein{'sup': −12', '−1', '−1, 'the photoelastic resin has a photoelastic constant at 25° C. of 1000×10Paor more and 100000×10−12 Paor less.'}6. The cushioning material having a sensor according to claim 1 , ...

Подробнее
28-01-2016 дата публикации

CYCLODEXTRIN

Номер: US20160024229A1
Принадлежит:

The invention provides a method for preparing sulphoalkyl ether-β-cyclodextrin. The method comprises first contacting cyclodextrin with a base to form activated cyclodextrin. The method then comprises separately contacting the activated cyclodextrin with an alkyl sultone to form sulphoalkyl ether-β-cyclodextrin. The activation reaction is carried in batch and the sulphoalkylation reaction is carried out under continuous flow conditions. 130-. (canceled)31. A method for preparing sulphoalkyl ether-β-cyclodextrin , the method comprising contacting cyclodextrin with a base to form activated cyclodextrin , and separately contacting the activated cyclodextrin with an alkyl sultone to form sulphoalkyl ether-β-cyclodextrin , characterised in that the sulphoalkylation reaction is carried out under continuous flow conditions.32. The method according to claim 31 , wherein the activation reaction is carried out as a batch process.33. The method according to claim 31 , wherein the base comprises an alkali metal hydroxide claim 31 , such as sodium hydroxide claim 31 , lithium hydroxide or potassium hydroxide claim 31 , preferably sodium hydroxide claim 31 , and wherein the molar ratio of base to cyclodextrin is within the range of 2:1 to 22:1 claim 31 , or 6:1 to 20:1 claim 31 , or 6:1 to 15:1.34. The method according to claim 31 , wherein the method comprises controlling the average degree of substitution (ADS) of sulphoalkyl ether β-cyclodextrin in the sulphoalkylation reaction by varying the base concentration in the activation reaction.35. The method according to claim 31 , wherein cyclodextrin is β-cyclodextrin claim 31 , and wherein the alkyl sultone comprises 1 claim 31 ,4-butane sultone.36. The method according to claim 31 , wherein the sulphoalkyl ether-β-cyclodextrin comprises sulphobutyl ether β-cyclodextrin (SBE-β-CD).37. The method according to claim 31 , wherein the activation reaction is conducted at atmospheric pressure claim 31 , and wherein the activation ...

Подробнее
22-01-2015 дата публикации

FLUORINE RESIN FILM

Номер: US20150024189A1
Принадлежит:

A fluorine resin film has a heat ray-shielding function, through which film it is possible to see natural colors of a colorless translucency, without any adverse effect on the high translucency, strong mechanical properties, robust weather resistance, and other properties inherent to a fluorine resin. The film provides mechanical properties, translucency, long-term weather resistance, and other properties of a fluorine resin film; which has excellent heat ray shielding; and through which natural colors can be seen with a colorless translucency. The film contains indium tin oxide having a mean particle size of 10-200 nm and a blue pigment having a mean particle size of 10-200 nm wherein the indium tin oxide content A (wt %) and blue pigment content B (wt %) in the film simultaneously satisfy 10/t≦A≦60/t and 0.05A≦B≦0.3A wherein t represents film thickness. 14-. (canceled)8. The fluorine resin film as described in claim 5 , wherein the blue pigment is cobalt blue.10. The fluorine resin film as described in claim 6 , wherein the blue pigment is cobalt blue.11. The fluorine resin film as described in claim 7 , wherein the blue pigment is cobalt blue. This disclosure relates to fluorine resin film with high heat ray shielding properties. More specifically, it relates to fluorine resin film with high heat ray shielding properties that is colorless and transparent and through which natural colors are clearly visible.With high weather resistance, transparency, mechanical properties, and moisture resistance, fluorine resin films have been used as greenhouse covering material, roofing film material, window material, solar cell surface protection material, condensing panel surface material, display plate surface material, building exterior material, and the like.In the fields of building materials including roofing film material and window material, in particular, demands for fluorine resin films have been increasing because of its advantages as an environment-conscious ...

Подробнее
17-04-2014 дата публикации

Biopolymer System for Tissue Sealing

Номер: US20140107065A1
Принадлежит:

A tissue sealant for use in surgical and medical procedures for sealing the tissues of a living mammal is provided. The tissue sealant comprises a hydrogel which is formed by gelation of a premix disposed on the tissue to be sealed. The premix comprises alkylated chitosan or a gelatin, and a polybasic carboxylic acid or an oxidized polysaccharide, in an aqueous medium. The premix can also include a dehydrating reagent, a carboxyl activating reagent, or both. A specific use of the tissue sealant is in the repair of the dura mater after brain surgery to prevent leakage of cerebrospinal fluid. The tissue sealant may include a therapeutic or protective agent such as an antibiotic or an anti-inflammatory drug. 1. A biocompatible , biodegradable composition for use in sealing a biological tissue of a living mammal , the composition comprising a hydrogel , the hydrogel being produced by mixing a first solution comprising an alkylated chitosan with a second solution comprising oxidized dextran , wherein the mixture , when applied to a biological tissue in need of sealing , forms a hydrogel within a minute after mixing thereby sealing the biological tissue.2. (canceled)3. The composition of wherein the hydrogel is adapted to adhere to biological tissue of a living mammal claim 1 , to adhesively seal the tissue.4. (canceled)5. The composition of wherein the alkylated chitosan comprises acrylated chitosan.611-. (canceled)12. The composition of wherein the living mammal is a living human being.1314-. (canceled)15. The composition of further comprising a therapeutic or protective agent.1625-. (canceled)27. (canceled)28. The method of wherein the hydrogel formed by gelation from the mixture adheres to the biological tissue on which it is disposed claim 26 , to adhesively seal the tissue.29. (canceled)30. The method of wherein the alkylated chitosan comprises an acrylated chitosan.3134-. (canceled)35. The method of further comprising dissolving the alkylated chitosan in the ...

Подробнее
26-01-2017 дата публикации

ACRYLIC RESIN COMPOSITION, METHOD FOR PRODUCING SAME, AND ACRYLIC RESIN FILM

Номер: US20170022334A1
Автор: Abe Junichi
Принадлежит: MITSUBISHI RAYON CO., LTD.

The purpose of the present invention is to provide an acrylic resin composition that is a raw material for an acrylic resin film which has an excellent appearance and in which occurrence of blocking is suppressed. The present invention is an acrylic resin composition that comprising an acrylic polymer (A), an anti-blocking agent (B), and a non-crosslinked acrylic polymer (C). The non-crosslinked acrylic polymer (C) is a polymer of a monomer component including 50% to 100% by mass of methyl methacrylate (c1), the polymer having a reduced viscosity of 0.2 to 2 L/g. 1. An acrylic resin composition comprising an acrylic polymer (A) , an anti-blocking agent (B) , and a non-crosslinked acrylic polymer (C) ,wherein the non-crosslinked acrylic polymer (C) is a polymer of a monomer component including 50% to 100% by mass of methyl methacrylate (c1), the polymer having a reduced viscosity of 0.2 to 2 L/g.2. The acrylic resin composition according to claim 1 , wherein the content of the anti-blocking agent (B) is 0.01 parts to 0.5 parts by mass claim 1 , and the content of the non-crosslinked acrylic polymer (C) is 0.1 parts to 5 parts by mass claim 1 , relative to 100 parts by mass of the acrylic polymer (A).3. The acrylic resin composition according to claim 1 , wherein the average primary particle size of the anti-blocking agent (B) is 5 nm to 10 μm.4. The acrylic resin composition according to claim 1 , wherein the anti-blocking agent (B) is in the form of inorganic particles.5. The acrylic resin composition according to claim 1 , wherein the anti-blocking agent (B) is silicon dioxide.6. The acrylic resin composition according to claim 1 , wherein the acrylic polymer (A) includes at least one of a rubber-containing polymer (A1) and a non-rubber-containing polymer (A2).7. The acrylic resin composition according to claim 6 , wherein the percentage content of the rubber-containing polymer (A1) in the acrylic polymer (A) is 10% to 100% by mass claim 6 , and the percentage ...

Подробнее
26-01-2017 дата публикации

OPTICAL RESIN COMPOSITION AND FILM

Номер: US20170022354A1
Принадлежит:

Disclosed herein are an optical resin composition whose orientation birefringence and photoelastic birefringence are both very low and which has high transparency and which provides a film having few surface defects, high heat stability, high solvent resistance, and excellent surface appearance, and a film comprising the optical resin composition. 4. The optical resin composition according to claim 1 , which contains the resin (A) in an amount of 1 to 99 parts by weight per 100 parts by weight of a total amount of the resin (A) and the resin (B).5. The optical resin composition according to claim 1 , further comprising multi-layered particles.6. The optical resin composition according to claim 5 , wherein the multi-layered particles are acrylic rubber particles.7. The optical resin composition according to claim 1 , wherein a photoelastic constant of the resin (A) and a photoelastic constant of the glutarimide acrylic resin (B) are opposite in sign.8. The optical resin composition according to claim 1 , wherein an orientation birefringence of the resin (A) and an orientation birefringence of the glutarimide acrylic resin (B) are opposite in sign.9. The optical resin composition according to claim 1 , wherein when a molded body (thickness: 125 μm) of a mixed resin comprising the resin (A) and the glutarimide acrylic resin (B) is prepared claim 1 , the molded body has a haze of 2% or less.10. The optical resin composition according to claim 1 , wherein a photoelastic constant of a mixed resin comprising the resin (A) and the glutarimide acrylic resin (B) is −10×10to +10×10Pa.11. The optical resin composition according to claim 1 , wherein an orientation birefringence of a mixed resin comprising the resin (A) and the glutarimide acrylic resin (B) is −15×10to +15×10.12. The optical resin composition according to claim 5 , wherein the multi-layered particles have a polymer layer containing claim 5 , as a structural unit claim 5 , a vinyl-based monomer having claim 5 , as ...

Подробнее
10-02-2022 дата публикации

HIGHLY FLEXIBLE VDF POLYMER

Номер: US20220041772A1
Автор: ABUSLEME Julio A.
Принадлежит:

The present invention pertains to vinylidene fluoride copolymers comprising recurring units derived from chlorotrifluoroethylene and from a (meth)acrylic monomer having improved flexibility, to a process for their manufacture, and to their use in applications where outstanding flexibility is required. 116-. (canceled)18. The polymer (A) according to claim 17 , having an intrinsic viscosity claim 17 , measured at 25° C. in N claim 17 ,N-dimethylformamide of at most 0.50 l/g.19. The polymer (A) according to claim 17 , having an intrinsic viscosity claim 17 , measured at 25° C. in N claim 17 ,N-dimethylformamide of at least 0.05 l/g.21. The polymer (A) according to claim 17 , wherein the amount of monomer (MA) is from 0.1% to 3% by weight claim 17 , with respect to the total weight of recurring units of polymer (A).22. The polymer (A) according to claim 17 , wherein comonomers (F) is selected from the group consisting of:{'sub': 2', '8, '(a) C-Cfluoro- and/or perfluoroolefins;'}{'sub': 2', '8, '(b) C-Chydrogenated monofluoroolefins;'}{'sub': 2', 'f0', 'f0', '1', '6, '(c) perfluoroalkylethylenes of formula CH═CH—R, wherein Ris a C-Cperfluoroalkyl group;'}{'sub': 2', 'f1', 'f1', '3', '2', '5', '3', '7', '4', '9', '5', '11, '(d) (per)fluoroalkylvinylethers of formula CF═CFORwherein Ris a perfluorinated alkyl group —CF(perfluoromethylvinylether (PMVE)), —CF(perfluoroethylvinylether (PEVE)), —CF(perfluoropropylvinylether (PPVE)), —CFor —CFgroup, and'}{'sub': 2', '6, '(e) chloro- and/or bromo- and/or iodo-C-Cfluoroolefins.'}23. The polymer (A) according to claim 17 , wherein comonomers (F) is HFP or PMVE.24. The polymer (A) according to claim 17 , which comprises:from 8 to 20% by weight of recurring units deriving from the CTFE monomer,from 0.4 to 1.5% by weight of recurring units deriving from hydrophilic (meth)acrylic monomer (MA) of formula (I),—from 0.7 to 2.0% by weight of recurring units deriving from comonomers (F),the percentages by weight being with respect to the ...

Подробнее
10-02-2022 дата публикации

Polyimide Film and Flexible Display Panel Including the Same

Номер: US20220041821A1
Принадлежит:

Provided are a polyimide-based film, a window cover film, and a display device including the same. More particularly, a polyimide-based based film which has a modulus of 5 GPa or more as measured using a universal testing machine (UTM) in accordance with ASTM D882, plastically deforms at a strain of 4% or more during stretching, and has a difference between a modulus in a machine direction Mmd and a modulus in a width direction Mtd satisfying the following Equation 1, is provided: 1. A polyimide-based film which has a modulus of 5 GPa or more as measured using a universal testing machine (UTM) in accordance with ASTM D882 , plastically deforms at a strain of 4% or more during stretching , and has a difference between a modulus in a machine direction Mmd and a modulus in a width direction Mtd satisfying the following Equation 1:{'br': None, 'i': 'Mmd−Mtd|≤', '|0.7 GPa.\u2003\u2003[Equation 1]'}2. The polyimide-based film of claim 1 , wherein an amount of energy required per a unit thickness μm of the polyimide-based film is 30 J/mor more claim 1 , at a point where plastic deformation occurs claim 1 , in a stress-strain curve measured using a universal testing machine (UTM).3. The polyimide-based film of claim 2 , wherein the amount of energy required per a unit thickness μm of the polyimide-based film is 30 to 100 J/m.4. The polyimide-based film of claim 1 , wherein a stress of the polyimide-based film is 1000 kgf/cmor more claim 1 , at a point where plastic deformation occurs.5. The polyimide-based film of claim 1 , wherein the polyimide-based film has a total light transmittance of 87% or more as measured at 400 to 700 nm in accordance with ASTM D1746 claim 1 , a light transmittance of 5% or more as measured at 388 nm in accordance with ASTM D1746 claim 1 , a haze of 2.0% or less claim 1 , and a yellow index of 5.0 or less.6. The polyimide-based film of claim 1 , wherein an elongation at break of the polyimide-based film is 15% or more in accordance with ASTM D882. ...

Подробнее
23-01-2020 дата публикации

RETARDATION FILM

Номер: US20200025989A1
Принадлежит: KANEKA CORPORATION

Provided are: a novel retardation film which has low photoelastic coefficient, while having good linear thermal expansion coefficient and water absorption; and the novel retardation film which additionally has high heat resistance. The above-described problem is solved by a retardation film which has an absolute value of the linear thermal expansion coefficient of 100 ppm/° C. or less, a glass transition temperature of 180° C. or more, a photoelastic coefficient of from 5×10m/N to 30×10m/N and a water absorption of 2.0 wt % or less, or a retardation film which has an absolute value of the linear thermal expansion coefficient of 100 ppm/° C. or less, a photoelastic coefficient of from 5×10m/N to 30×10m/N and a water absorption of 2.0 wt % or less. 1: A phase difference film having a coefficient of linear thermal expansion of 100 ppm/° C. or less in absolute value , a glass transition temperature of 180° C. or more , a photoelastic coefficient of 5×10m/N to 30×10m/N and a water absorption rate of 2.0 wt % or less.2: A phase difference film having a coefficient of linear thermal expansion of 100 ppm/° C. or less in absolute value , a photoelastic coefficient of 5×10m/N to 30×10m/N and a water absorption rate of 2.0 wt % or less.3: The phase difference film according to claim 1 ,wherein the phase difference film has an initial value of in-plane retardation Re(550) of 130 nm to 160 nm,when the phase difference film is subjected to a dry heat durability test (80° C.×1,000 hrs), an amount of change in the in-plane retardation Re is within 2.0% of the initial value, andwhen the phase difference film is subjected to a wet heat durability test (60° C./90% RH×1,000 hrs), an amount of change in the in-plane retardation Re is within 4.0% of the initial value.4: The phase difference film according to claim 1 , wherein the phase difference film has a thickness of 50 μm or less and reverse wavelength dispersion Re(450)/Re(550) of 0.50 to 0.99.6: The phase difference film according ...

Подробнее
02-02-2017 дата публикации

Method of Using Cyclodextrin-Based Metal Organic Frameworks

Номер: US20170028383A1
Принадлежит:

This disclosure relates to a method that includes (1) contacting a solvent with a porous cyclodextrin-based metal organic framework (CD-MOF) adsorbed with COto release CO, and (2) collecting the released CO. The CD-MOF includes at least a metal cation and a plurality of cyclodextrin components. 1. A method , comprising:{'sub': 2', '2, 'contacting a solvent with a porous cyclodextrin-based metal organic framework (CD-MOF) adsorbed with COto release CO, the CD-MOF comprising at least a metal cation and a plurality of cyclodextrin components; and'}{'sub': '2', 'collecting the released CO.'}2. The method of claim 1 , wherein the CD-MOF adsorbed with COcomprises at least about 4% by weight of CO.3. The method of claim 1 , wherein the CD-MOF adsorbed with COcomprises at most about 10% by weight of CO.4. The method of claim 1 , wherein the solvent is Calcohol claim 1 , Calkane claim 1 , methylene chloride claim 1 , water claim 1 , acetone claim 1 , acetic acid claim 1 , acetonitrile claim 1 , benzene claim 1 , toluene claim 1 , dimethylformamide claim 1 , or a mixture thereof.5. The method of claim 1 , wherein the solvent is saturated with CO.6. The method of claim 1 , wherein the solvent is in the form of a liquid or a vapor.7. The method of claim 1 , wherein the cyclodextrin is γ-cyclodextrin.8. The method of claim 1 , wherein the metal cation is a Group I metal cation claim 1 , a Group II metal cation claim 1 , or a transition metal cation.9. The method of claim 8 , wherein the metal cation is Na claim 8 , K claim 8 , Rb claim 8 , or CS.10. The method of claim 1 , wherein claim 1 , prior to the contacting step claim 1 , the method further comprises disposing a CD-MOF in a gas comprising at least about 0.04% by volume of COto form the CD-MOF adsorbed with CO.11. The method of claim 10 , wherein the gas comprises at most about 25% by volume of CO.12. The method of claim 10 , further comprising transferring the CD-MOF adsorbed with COinto a regeneration vessel prior to the ...

Подробнее
02-02-2017 дата публикации

Cyclic-diene Additives in Polyethylene Films and Enhanced Film Orientation Balance in Production Thereof

Номер: US20170028605A1
Принадлежит:

A method of forming a blown film comprising extruding a molten composition through a die opening to form a film; wherein the molten composition comprises at least one polyethylene and within the range from 0.10 wt % to 10 wt % of a cyclic-diene terpolymer by weight of the composition; causing the film to progress in a direction away from the die opening; cooling the film at a distance from the die opening, the distance adjusted to effect the properties of the film; and isolating a blown film therefrom. 1. A method of forming a blown film comprising:extruding a molten composition through a die opening to form a film; wherein the molten composition comprises at least one polyethylene and within the range from 0.10 wt % to 10 wt % of a cyclic-diene terpolymer (CDTP) by weight of the composition;causing the film to progress in a direction away from the die opening;cooling the film at a distance from the die opening, the distance adjusted to effect the properties of the film; andisolating a blown film therefrom.2. The method of claim 1 , wherein the polyethylene has a SHR (150° C.) within a range from 1.0 to 3.0 per 1 wt % of CDTP present in the composition.3. The method of claim 1 , wherein the polyethylene is a linear low density polyethylene (LLDPE) having a density within the range from 0.850 g/cmto 0.930 g/cm.4. The method of claim 1 , wherein the polyethylene has a molecular weight distribution (Mw/Mn) within the range from 1.8 to 4.0.5. The method of claim 1 , wherein the CDTP is a terpolymer comprising ethylene-derived units claim 1 , Cto Cα-olefin derived units claim 1 , and cyclic diene-derived units; wherein the cyclic diene-derived units are selected from the group consisting of dicyclopentadiene (DCPD) claim 1 , norbomadiene (NBD) claim 1 , 5-vinyl-2-norbornene (VNB) claim 1 , ethylidene norbornene (ENB) claim 1 , derivatives thereof claim 1 , and combinations thereof.6. The method of claim 1 , wherein the CDTP comprises ethylene claim 1 , within a range ...

Подробнее
29-01-2015 дата публикации

Production Of Stabilized Channel Type Cyclodextrin Crystals

Номер: US20150031532A1
Принадлежит: Amphidex A/S

The present invention relates to stabilized channel type cyclodextrin crystals. In particular the present invention relates to a method for producing stabilized channel type cyclodextrin crystals, stabilized channel type cyclodextrin crystal comprising a stabilizer, uses of said stabilized crystals and products comprising stabilized channel type cyclodextrin crystals. 1. A method for producing channel type cyclodextrin crystals comprising the steps of:a) Providing a solution of cyclodextrin further comprising a water-soluble stabilizer with a vapour pressure of less than 1 mmHg at 25 degrees Celsius, and at least 2 hydrogen bond donors and/or acceptors; wherein the liquid matter of the solution of cyclodextrin comprises at least 50% w/w of water;b) Contacting said solution with a non-solvent system having a Snyder polarity index (P′) of less than 6.6 to precipitate channel type cyclodextrin co-precipitated with said stabilizer;c) Separating the precipitated channel type cyclodextrin co-precipitated with said stabilizer from the solution and non-solvent system;wherein the molar ratio between cyclodextrin and stabilizer in said solution is at least 1:0.0001.2. A method for producing channel type cyclodextrin crystals according to claim 1 , provided that when the cyclodextrin is an α-cyclodextrin claim 1 , and when the non-solvent system does not comprise an alcohol claim 1 , the non-solvent system has a relative polarity of less than 0.229 and a Snyder polarity index (P′) of less than 5.4;provided that when the cyclodextrin is an α-cyclodextrin, and when the non-solvent system comprises an alcohol, the non-solvent system has a Snyder polarity index (P′) of less than 5.4;provided that when the cyclodextrin is an β-cyclodextrin, and when the non-solvent system does not comprise an alcohol, the non-solvent system has a relative polarity of less than 0.164 and a Snyder polarity index (P′) of less than 5.4;provided that when the cyclodextrin is an β-cyclodextrin, and when ...

Подробнее
02-02-2017 дата публикации

METHOD AND COMPOSITION TO ENSURE DEGRADATION OF PLASTIC FILMS IN AN ANAEROBIC ENVIRONMENT, SUCH AS A LANDFILL

Номер: US20170029582A1
Принадлежит:

A plastic film is produced by blending a polymer with particles encapsulating an oxidizing agent, such as hydrogen peroxide. Optionally, an “oxodegradable” and/or “oxo biodegradable” additive that promotes degradation of the polymer in the presence of oxygen may be blended into the plastic film. The presence of the oxidizing agent within the plastic film ensures degradation of an article of manufacture, e.g., a plastic bag, when it is disposed of in an anaerobic environment, such as a landfill. In some embodiments, the particles are microcapsules and/or nanocapsules each having a polymer shell encapsulating a core that includes the oxidizing agent. In some embodiments, the particles are microparticles and/or nanoparticles each having a matrix in which the oxidizing agent is encapsulated. 1. An article of manufacture , comprising:a plastic film comprising a polymer blended with particles encapsulating an oxidizing agent.2. The article of manufacture as recited in claim 1 , wherein the oxidizing agent is selected from the group consisting of hydrogen peroxide claim 1 , permanganates claim 1 , and mixtures thereof.3. The article of manufacture as recited in claim 1 , wherein the oxidizing agent comprises hydrogen peroxide.4. The article of manufacture as recited in claim 1 , wherein the particles comprise at least one of microcapsules and nanocapsules each having a shell encapsulating a core comprising the oxidizing agent.5. The article of manufacture as recited in claim 4 , wherein the oxidizing agent comprises hydrogen peroxide.6. The article of manufacture as recited in claim 1 , wherein the particles comprise at least one of microparticles and nanoparticles each having a matrix encapsulating the oxidizing agent.7. The article of manufacture as recited in claim 6 , wherein the oxidizing agent comprises hydrogen peroxide.8. The article manufacture as recited in claim 1 , wherein the plastic film further comprises at least one of an “oxodegradable” and “oxo ...

Подробнее
04-02-2016 дата публикации

POLYIMIDE PRECURSOR AND POLYIMIDE

Номер: US20160032056A1
Принадлежит:

The present invention relates to a polyimide precursor comprising a repeating unit represented by the following chemical formula (1): 112-. (canceled)14. The polyimide precursor according to claim 13 , wherein the six-membered rings in A have a crosslinked cyclic form claim 13 , in which carbon atoms constituting the ring chemically bind to each other to form another ring.17. The polyimide precursor according to claim 13 , wherein B is at least one selected from the group consisting of the chemical formulae (4-1) to (4-3).18. The polyimide precursor according to claim 17 , wherein Arto Arin the chemical formula (4-1) to (4-3) are each independently a benzyl or biphenyl divalent group.19. The polyimide precursor according to claim 18 , wherein the bonding position of benzene or biphenyl as Arto Arfor forming a polyimide main chain is the para position.21. The polyimide precursor according to claim 13 , obtained from a tetracarboxylic acid component providing the repeating unit represented by chemical formula (1) in an amount of 70 mole % or more and other tetracarboxylic acid components in an amount of 30 mole % or less based on 100 mole % of the total tetracarboxylic acid components claim 13 , and a diamine component providing the repeating unit represented by chemical formula (1) in an amount of 70 mole % or more and other diamine components in an amount of 30 mole % or less based on 100 mole % of the total diamine components.22. The polyimide precursor according to claim 21 , wherein the other diamine component is at least one selected from the group consisting of oxydianiline claim 21 , p-phenylenediamine claim 21 , m-phenylenediamine claim 21 , benzidine claim 21 , 3 claim 21 ,3′-dimethylbenzidine claim 21 , 2 claim 21 ,2′-dimethylbenzidine claim 21 , p-methylene bis(phenylenediamine) claim 21 , bis(aminophenoxy)benzene claim 21 , bis[(aminophenoxy)phenyl]hexafluoropropane claim 21 , bis(aminophenyl)hexafluoropropane claim 21 , bis(aminophenyl)sulfone claim 21 , ...

Подробнее
04-02-2016 дата публикации

Optical Film

Номер: US20160032063A1
Принадлежит:

Disclosed is an optical film having low wavelength dispersibility which is obtained by stretching a film formed of a fluorine-containing cyclic olefin polymer including at least one selected from a repeating structural unit represented by the formula described below, wherein a phase difference at a wavelength of 550 nm is greater than or equal to 50 nm, wavelength dispersibility represented by a ratio Re (400 nm)/Re (550 nm) of a phase difference Re (400 nm) at a wavelength of 400 nm to a phase difference Re (550 nm) at a wavelength of 550 nm is 1.00 to 1.05, wavelength dispersibility represented by a ratio Re (400 nm)/Re (800 nm) of a phase difference Re (400 nm) at a wavelength of 400 nm to a phase difference Re (800 nm) at a wavelength of 800 nm is 1.00 to 1.05, and total light transmittance is greater than or equal to 92%. 2. The optical film according to claim 1 ,wherein the optical film is a λ/4 wavelength plate or a λ/2 wavelength plate.3. The optical film according to claim 2 , obtained by subjecting a varnish of the fluorine-containing cyclic olefin polymer to fine filtration by passing the varnish through a filter including a hole having a hole diameter of less than or equal to 0.5 μm and subsequently forming a film claim 2 , wherein the optical film is a λ/4 wavelength plate or a λ/2 wavelength plate.4. The optical film according to claim 3 ,wherein in the λ/4 wavelength plate, a phase difference at a wavelength of 550 nm is 140±10 nm.5. The optical film according to claim 3 ,wherein in the λ/2 wavelength plate, a phase difference at a wavelength of 550 nm is 280±20 nm.6. The optical film according to claim 3 ,{'sup': '2', 'wherein in the λ/4 wavelength plate and the λ/2 wavelength plate, phase difference unevenness at a wavelength of 550 nm is less than or equal to ±0.50 nm/cm.'}7. The optical film according to claim 3 ,wherein in the λ/4 wavelength plate and the λ/2 wavelength plate, reflectance at a wavelength of 550 nm is less than or equal to 7.0%.8. ...

Подробнее
04-02-2016 дата публикации

ENCAPSULANT SHEET FOR SOLAR CELL

Номер: US20160032064A1
Автор: Yoda Hiroaki
Принадлежит:

An encapsulant sheet for a solar cell contains not less than 91% but less than 99% by mass of an ethylene-unsaturated ester copolymer (A), more than 1% but not more than 9% by mass of an olefin resins (B), 0.001 parts to 5 parts by mass of silicon dioxide and 0.001 to 0.5 parts by mass of a silane coupling agent, where the sum total of the content of the ethylene-unsaturated ester copolymer (A) and the content of the olefin resin (B) is taken as 100% by mass. The content of the silicon dioxide and the content of the silane coupling agent are relative to the total content of the ethylene-unsaturated ester copolymer (A) and the content of the olefin resin (B) being taken as 100% by mass. The encapsulant sheet is excellent in insulating property, storage stability, transparency, and durability of adhesion to glass. 1. An encapsulant sheet for a solar cell comprising:not less than 91% by mass but less than 99% by mass of an ethylene-unsaturated ester copolymer (A) that comprises monomer units derived from ethylene and monomer units derived from at least one unsaturated ester selected from the group consisting of vinyl acetate, vinyl propionate, methyl acrylate, ethyl acrylate, butyl acrylate, methyl methacrylate, and ethyl methacrylate, and that fails to comprise monomer units derived from acrylic acid, methacrylic acid, or any unsaturated carboxylic glycidyl ester, wherein the content of the monomer units derived from ethylene is 60% by mass to 80% by mass and the content of the monomer units derived from the at least one unsaturated ester is 20% by mass to 40% by mass where the content of the monomer units derived from ethylene and the content of the monomer units derived from the at least one unsaturated ester are each relative to the sum total of the two contents being taken as 100% by mass,more than 1% by mass but not more than 9% by mass of at least one olefin resin (B) selected from the group consisting of an ethylene-(meth) acrylic acid copolymer comprising ...

Подробнее
04-02-2016 дата публикации

Anti-corrosive coating compound

Номер: US20160032110A1
Принадлежит: EWALD DOERKEN AG

An anti-corrosive coating compound with: component I: cathodically active metal particles and component II: binder in the presence of water. In order to improve the service life of the coating compound, it is provided that an oxygen compound or a mixture of oxygen compounds of the subgroup elements, namely ammonium, alkaline or earth alkaline salts of an acid of a transition metal, is added as component III. The invention further relates to a method for producing an anti-corrosive coating compound, a workpiece coated with the anti-corrosive coating compound and the use of an oxygen compound or a mixture of oxygen compounds of the subgroup elements in an anti-corrosive coating compound.

Подробнее
04-02-2016 дата публикации

Amphiphilic Graft Copolymer for Waterborne Shape Memory Coatings

Номер: US20160032140A1
Принадлежит: SYRACUSE UNIVERSITY

A waterborne shape memory polymer coating that gives textiles and fibers good shape memory performance. An amphiphilic, crosslinkable grafted polysaccharide polymer was synthesized and provided in a water dispersion that can be applied to a flexible fibrous material and then crosslinked to yield good shape memory properties. The polymer coating showed good binding to human hair, which could be styled into a permanent shape (e.g., straight) during the crosslinked step. Next, this permanent shape can be styled to a temporary shape (e.g. curly) by heating and styling, and cooling. Finally, the permanent style can be regained by activation with water, heat, or both. 1. A graft polymer coating , comprising:a polymer backbone comprising a water soluble polysaccharide; anda side chain comprising a hydrophobic oligomer grafted onto said polymer backbone.2. The coating of claim 1 , wherein said water soluble polysaccharide is positively charged.3. The coating of claim 2 , wherein said water soluble polysaccharide comprises chitosan.4. The coating of claim 1 , wherein said grafting chain comprises poly(ε-caprolactone).5. The coating of claim 1 , wherein said polymer backbone and said grafting chain are dispersed in water via micellization.6. The coating of claim 1 , wherein said polymer backbone is covalently crosslinked.7. The coating of claim 6 , wherein said melting transition temperature is about 50° C.8. A method of providing shape memory to fibers claim 6 , comprising the steps of:coating an aqueous dispersion of a polymer backbone comprising a water soluble polysaccharide and a side chain comprising a hydrophobic oligomer grafted onto said polymer backbone onto at least one fiber; andapplying a cross-linker solution to crosslink the polymer backbone.9. The method of claim 8 , wherein the cross-linker is selected from the group consisting of dimethyl 3-3 claim 8 , dithio bis′ propionimidate (DTBP) claim 8 , neopentyl glycol diglycidyl ether (NGDE) claim 8 , and 1 claim ...

Подробнее
17-02-2022 дата публикации

NOVEL TRICARBOCYANINE-CYCLODEXTRIN(S) CONJUGATES AND USE THEREOF

Номер: US20220047724A1
Принадлежит:

The invention relates to novel tricarbocyanine-cyclodextrin(s) conjugates useful as markers in the diagnosis of kidney diseases, diagnostic compositions comprising the conjugates, their use, and their production. 2. The fluorescent compound according to claim 1 , wherein m is equal to 7 or 8.3. The fluorescent compound according to claim 1 , wherein at least one of the R′ claim 1 , R″ claim 1 , R′″ groups is selected from OCH claim 1 , OCHCH claim 1 , OCHCHOHCH claim 1 , whit the provision that at least one group from R′ claim 1 , R″ claim 1 , R′″ is OH.4. The fluorescent compound according to claim 1 , wherein R′ and R″ are OH claim 1 , and R′″ is selected from OCH claim 1 , OCHCH claim 1 , OCHCHOHCH claim 1 , wherein the substitution degree of R′″ is comprised between 0.5 and 1.5 for each unit of Formula (III).5. The fluorescent compound according to claim 4 , wherein R′″ is OCHCHOHCH6. The fluorescent compound according to claim 1 , wherein Rand Rare independently selected from H claim 1 , SOH and COOH.7. The fluorescent compound according to claim 1 , wherein Rand Rare independently selected from methyl claim 1 , ethyl claim 1 , (CH)COOH claim 1 , (CH)SOH claim 1 , (CH)N(CH).11. A fluorescent compound according to for use in the diagnosis of kidney function in a mammal.12. The fluorescent compound according to for use in determining the glomerular filtration rate.13. A diagnostic formulation for use in the diagnosis of kidney function claim 1 , comprising at least one fluorescent compound according to .14. A method for diagnosing kidney function of a mammal claim 1 , comprising:{'claim-ref': {'@idref': 'CLM-00001', 'claim 1'}, '(a) administering to the mammal at least one fluorescent compound according to , and'}(b) detecting and measuring the fluorescence emission of the at least one fluorescent compound.15. The method according to claim 14 , wherein the administration is intravenous.16. The method according to claim 14 , wherein the fluorescence detection and ...

Подробнее